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ABSTRACT 
Background: Diverticular disease of the colon is common and is associated with a high and 
increasing societal burden with great economical and human costs. Prevalence increases with 
age and with an overall aging population, investigating risk factors are important. The 
pathogenesis is complex and poorly understood. Low-grade inflammation and gut dysbiosis 
have been suggested to play a role but population studies are lacking. While genetic and 
lifestyle factors have been associated with increased risk for complicated diverticular disease 
in adults, environmental risk factors are underexplored. The aim of this thesis was to 
investigate the prevalence of diverticulosis, its association with gastrointestinal symptoms 
and colonic inflammation in a general population, and to identify early lifestyle and 
environmental risk factors for developing future symptomatic diverticular disease, in a young 
population. 
Methods and Main results: In paper I, we performed a population-based colonoscopy 
study of randomly selected adults born in Sweden (18–70 years old) assessing the association 
between abdominal symptoms, mental health, colonoscopy findings and diverticulosis 
(n=742). We found the prevalence of diverticulosis to be age-dependent and diverticulosis 
was associated with diarrhea across all age groups. In those older than 60 years of age, 
diverticulosis was further associated with abdominal pain and diarrhea-predominant IBS. In 
paper II, a nested case control study from paper I was performed (n=127 cases with 
diverticulosis and n=127 controls). The findings were that in a general community sample, 
neither asymptomatic nor symptomatic diverticulosis, were associated with serological or 
colonic mucosal inflammation. Other explanations for symptomatic colonic diverticulosis 
need to be identified. Papers III and IV were population-based cohort studies of Swedish 
male conscripts ages 18-20, investigating the association between lifestyle and environmental 
exposure variables, and symptomatic diverticular disease requiring hospitalization from 
1969-2009 (n=49,321). In papers III and IV, we found that exposure to parental divorce, 
being overweight or obese, a smoker, a risk user of alcohol and/or having low cardiovascular 
fitness in late adolescence is associated with an increased risk of hospitalized diverticular 
disease later in life.  
Conclusions: Diverticulosis is common, age-dependent and associated with diarrhea and 
age-specific symptoms but not inflammation. Early adulthood lifestyle and environmental 
factors such as obesity, smoking, risky alcohol use, physical inactivity and early adverse 
events such as parental divorce increase the risk for developing severe diverticular disease. 
Future studies investigating alternate pathophysiologic mechanisms for diverticulosis are 
needed and prospective age-specific studies evaluating early life events and the role of 
modified lifestyle risk factors and course of diverticular disease are recommended. 
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1 INTRODUCTION AND RATIONALE 
Diverticular disease is a highly common gastrointestinal condition in the Western world (US, 
Europe and Australia). In the US, it represents the eighth most costly gastrointestinal disease 
with an estimated economic burden of 2.7 billion USD per year.(1) European data estimate 
diverticular disease to account for 786,000 hospital admissions per year and 23,605 deaths 
per year.(2) Comparable data exist in Sweden reports of rising rates of hospitalization for 
diverticular disease by 14% was noted between 2002 and 2014.(3) 
Colonic diverticula are small outpouchings of mucosal and submucosal layers of the colonic 
wall. While the majority of persons with diverticulosis are asymptomatic, 15-20 % develops 
symptoms.(4) The clinical picture of diverticular disease ranges from an acute presentation 
with complicated diverticulitis, perforation, abscess, strictures or fistulas to a chronic 
presentation with recurrent abdominal pain and change in bowel habits. In addition, long-
term complications such as recurrent episodes of diverticulitis(5), new onset  irritable bowel 
syndrome (IBS) and mood disorders(6) after a diverticulitis event as well as reduced quality 
of life(4) have all been implicated in diverticular disease. 
True incidence and prevalence of diverticulosis is unclear though since most affected 
individuals lack symptoms. Diverticulosis is however the most common colonoscopy finding 
and it has been estimated that in the US, slightly less than three thirds of the US population 
will be have diverticulosis by the age of eighty.(7) 
The epidemiologic profile of diverticular disease is dominated by age and geography. For 
many decades diverticular disease has been considered a disease of Western civilization. (8)  
The countries with the highest prevalence rates are thus the Western countries, i.e. USA, 
Europe and Australia while it is rare in rural Africa and Asia. An inverse association with 
fiber intake is thought to play a role in the etiology and geographical variation.(8) Further, in 
these countries, diverticular disease is age prevalent, rarely affecting individuals younger than 
40 years of age (<10%) but commonly (>70%) affecting elderly ages 70 and older.(7) 
In spite of its worldwide socioeconomic impact and increasing prevalence of our aging and 
expanding population, the pathogenesis is not well understood. It is recognized to be 
multifactorial and complex. Twin studies have established a role for genetic factors 
increasing the risk for diverticular disease requiring hospitalization.(9, 10) Other factors 
such as lifestyle factors like diet, obesity, smoking, alcohol, physical inactivity and 
medications have also been found to play important roles.(11-16) The interaction and 
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interplay between genetic and non-genetic factors are thus suggested but the exact 
mechanisms are still unclear. 
The main rationale for this project was to elucidate the prevalence of diverticulosis, its 
association with gastrointestinal symptoms and pathophysiology, namely, colonic 
inflammation, in a general population. Further it was to identify early lifestyle and 
environmental risk factors for developing future symptomatic diverticular disease in a young 
population. 
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2 BACKGROUND 
2.1 Definition 
Colonic diverticula are sac-like protrusions of mucosa and submucosa through the muscular 
colonic wall at weak points in the circular muscle where blood vessels, the vasa recta, enter to 
supply the mucosa. The size of a diverticulum is typically 3 -10 mm in diameter. Diverticula 
are really false diverticula as only the mucosa and submucosa, are involved. Diverticula may 
localize throughout the colon but sigmoid colon is the most commonly affected colonic 
segment.(17) 
2.2 Terminology 
The terminology used in the medical literature remains poorly defined. In the past, the term 
diverticular disease was often loosely used as an umbrella diagnosis including both 
diverticulosis regardless of symptom status and diverticulitis, while more recently it 
includes any type of symptomatic diverticulosis. Several propositions to nomenclature exist 
with aim to clarify diverticular terminology and add evolutionary linkages.(4, 18) In this 
thesis, I use the latter definition where diverticular disease is the umbrella diagnosis for 
clinically significant symptomatic diverticulosis. See nomenclature in Figure 1. 
 
Figure 1. Nomenclature chart adapted and modified from Strate et al. Am J Gastroenterol 2012 (4) 
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Diverticulosis is the presence of diverticula in the colon and may be asymptomatic or 
symptomatic. While most individuals affected with diverticulosis are asymptomatic, 20% are 
symptomatic. 
Diverticular Disease is defined as clinically significant and symptomatic diverticulosis, in 
which diverticulosis has escalated to an illness.(18) 
Symptomatic Diverticular Disease, namely, symptomatic uncomplicated diverticular 
disease (SUDD) is a distinct clinical subtype of diverticular disease with persistent abdominal 
symptoms secondary to diverticula but without obvious colitis or diverticulitis.(19) The 
current definition though is controversial with wide range of included symptoms. While some 
define SUDD as the presence of abdominal pain and change in bowel habits attributed to 
diverticula in the absence of alternate etiologies (19-21) others define it as abdominal pain or 
change in bowel habits in the presence of diverticulosis and absence of alternate etiologies 
(4), or the presence of any symptoms in diverticular disease as symptomatic diverticular 
disease.(22) 
Diverticulitis is the inflammation and/or infection of a diverticulum. The clinical picture is 
either acute or chronic and uncomplicated or complicated.  
Complicated Diverticular Disease occurs when abscess, fistula, colonic obstruction or free 
perforation secondary to inflamed diverticula occurs. While small pericolic abscesses are 
secondary to microperforation, extensive abscesses, or fistula formations are from large 
perforations. Other complications include frank bacterial/ fecal peritonitis, which may be life-
threatening. 
Chronic or “smoldering” diverticulitis is defined as a subset of uncomplicated diverticulitis 
characterized by poor response to antibiotics, rebound symptomatology when stopping 
treatment and/or continued subclinical inflammation without complete resolution after the 
initial episode.(23)  
Segmental Colitis Associated with Diverticulosis (SCAD) is a poorly understood but 
distinct type of diverticular disease characterized by macroscopic colonic mucosal 
inflammation in segments affected by diverticulosis.(24, 25)  
Diverticular hemorrhage is the bleeding from a diverticulum. To date it is the most common 
cause of significant lower gastrointestinal bleeding (LGIB) in adults and accounts for 
approximately 33.1% of all lower GI bleeding etiologies in the Western countries.(26)  
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2.3 History 
 
Diverticula have been discussed in the medical literature for centuries. In 1815 Fleischman 
introduced the term, “divertikel”(27) followed by a histopathological description of 
diverticula in 1849 by the French pathologist Jean Cruveilhier.(28) Diverticulitis was not 
described until 1899 in Germany by the surgeon Ernst Graser.(29) In the 20th century the 
medical literature on diverticular disease flourished. In 1904, Beer proposed the 
diverticulitis process with impaction of feces in the neck of diverticula causing 
inflammation and possible abscess and fistula.(30) Soon thereafter in 1907, reports of the 
first diverticulitis indicated surgical resection was published by Mayo and colleagues.(31) 
Diverticulosis case series with radiological images was published in 1914.(32) The 
proposed process in the diverticular disease was soon classified by Telling and Gruner (33) 
and Spriggs and Marxer(27) in 1917 and 1925, respectively. 
 
Early recognition of age being an important key player in diverticular disease is well 
documented in literature.(34) In 1969, Parks published the first study on natural history of 
diverticular disease.(35) In his retrospective review of 455 inpatients out of a total 521 
patients overall, during the years 1951-1965, he found a female predominance of 
diverticular disease requiring inpatient care but similar age of onset of symptoms among 
genders in the sixth to eighth decade of age, which holds true today. Similar to current data, 
diverticular disease was noted to be rare in individuals younger than 40 years of age.   
2.4 Epidemiology 
2.4.1 Prevalence and incidence 
 
Since diverticulosis is predominantly asymptomatic, the true prevalence of colonic 
diverticulosis is difficult to determine. In contrast, data on diverticular disease, which by 
definition is symptomatic, exist.  
Diverticular disease was recently reported to be the eighth most frequent outpatient 
gastrointestinal diagnosis in the US with diverticulitis accounting for approximately 
157,000 cases of hospital admissions, a 31% increase compared to 2006.(1) In Sweden, 
data from the National Patient Registry (NPR), suggest similar trends as noted in the US. 
Based on ICD diagnosis for diverticular disease (K57), a 14% rise in discharge diagnoses 
for hospital admissions was noted between 2002 and 2014.(3)  
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Diverticular hemorrhage is estimated to occur in 3% to 5% of all patients with 
diverticulosis.(36) Temporal trend data from the US though, found diverticular hemorrhage 
to be the most frequent diagnosis of LGIB requiring hospital admission and was associated 
with a17% increase in hospital admissions between 2006 and 2012.(1) Similarly, a recent 
nationwide UK audit study found diverticular bleeding to be the most common diagnosis 
for LGIB (26.4%) in the UK.(37)  
SCAD prevalence is reportedly 0.3% to 1.3% in the US population with diverticulosis, with 
a slight male predominance (58.7%) and mean age of 63.6 years.(38)  
2.4.2 Age and gender  
Within the spectrum of diverticular disease, the medical literature suggests existing age and 
gender differences. As described in the introduction age plays a key role in the prevalence 
and incidence of diverticulosis and diverticular disease.(1, 7, 8) Different and additional 
aspects will be discussed below.  
While diverticulosis per se does not appear to have a gender difference (39, 40), 
diverticular disease does. In the US, complicated diverticular disease and diverticular 
bleeding incidence seem to be higher in men   (5, 41), while women seem to suffer more 
diverticulitis episodes, more severe episodes requiring hospitalizations and recurrent 
diverticulitis.(5, 42, 43)  
In regards to age some additional important epidemiological differences need to be 
mentioned. While diverticular disease is rare (2-5%) in individuals younger than age 40 years, 
a time trend population-based study from the US suggest a more significant increment in the 
incidence of diverticulitis in the younger population compared to the older population.(5) In 
the same study, the younger population affected by diverticulitis was noted to have a reversed 
gender difference with a male predominance. Other reported differences seem to exist in the 
natural history, where the severity, recurrence, complication rate of diverticulitis and need for 
urgent surgery, was noted to be higher in the younger population than in the older 
population.(44-46) Lastly, age also seems to associate with the progression of the 
diverticulosis by increasing number of diverticula with age. In a large US screening 
population colonoscopy-based study the proportion of patients with more than 10 
diverticula was noted to increase with age: 8%, 15% and 30% in age categories: 50 years or 
younger; 51-60 years; older than 60 years, respectively.(47)  
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2.4.3 Geography  
Prevalence studies over the years have time and again shown a Western-dominant prevalence 
of diverticulosis (e.g., the United States, Europe, and Australia) while being rare in rural 
Africa and Asia.(8) One postulated explanation is the low fiber diet in Western countries.(48) 
Migrant studies further support the importance of geography. A Swedish population-based 
migrant study found that immigrants from low prevalence countries in Africa, Asia and 
Middle East had increased rates of hospital admission from diverticular disease within 10 
years of moving to Sweden.(49) In addition, an older autopsy study of Japanese-born 
immigrants to Hawaii, found immigrants to have a higher prevalence of diverticulosis than 
Japanese natives living in Japan.(50)  
However, with an overall aging population worldwide, ongoing migration and globalization 
and assimilation to Western diet and lifestyle behaviors, a rising incidence of diverticular 
disease are expected. This notion is already supported by studies from non-Western countries, 
such as Israel, Korea, Japan, Kenya, Singapore, and Uganda where reports of increasing 
prevalence of diverticulosis compared to previous estimates have been noted.(51-55) 
2.4.4 Risk Factors 
2.4.4.1 Heritable Risk Factors 
To date, two large Scandinavian population-based twin studies confirm the role of heritability 
in symptomatic diverticular disease. The first study is a Swedish twin study, which linked the 
Swedish National Patient Registry (NPR) to the Swedish Twin Registry.(9) The study 
included 104,452 twins born from 1886 to 1980, of which 2296 were hospitalized for 
diverticular disease. The authors found that monozygotic twins had an OR of 7.15 (95% 
confidence interval (CI) = 4.82–10.61) for developing the diverticular disease requiring 
hospital admission if the co-twin was affected. By contrast, the same gender dizygotic twins 
only had an OR of 3.20 (95%CI= 2.21-4.63). Given that monozygotic twins share 100% of 
genome and dizygotic twins only 50%(56), a heritability component was thus confirmed and 
calculated to account for 40% and non-shared environmental factors 60%. Comparable results 
were reported from the Danish twin study with linkage to the Danish NPR finding a relative risk for 
requiring hospitalization for diverticular disease of 2.92 (95% CI= 2.50–3.39) in siblings of cases, 
and heritability estimated to be 53% (95% CI= 45–61%), accordingly.(10)  
More recent studies have explored heritability by association and genome wide association 
studies (GWAS). In 2014, the single nucleotide polymorphisms (SNPs) rs784647 on the 
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TNFSF15 gene was noted to be associated with diverticulitis requiring surgery in a small 21 
patient study compared to controls with healthy colon, ulcerative colitis and Crohn’s disease. 
The TNFSF15 gene has immunoregulatory and angiostatic properties and has been associated with 
IBD in GWAS studies.(57) Earlier, a coincidental finding of the association between a SNPs 
of the Reprimo gene (with cell proliferative regulatory properties) was found to associate 
with Caucasians patients with diverticular disease in a colorectal cancer association 
study.(58) But both studies were small in size. A third and large study (n=707) found another 
SNP linked with diverticulosis. A variant of COL3A1 gene (rs3134646) (associated with 
collagen disorders and herniation) was noted to be associated with colonic diverticulosis in 
white men in a German population even after adjusting for confounders(59), further 
supporting heritability and possible collagen alteration to play a role. However, these finding 
are only applicable to Caucasians of European decent.  
The first GWAS study evaluating sequence variants affecting the risk of diverticulitis and 
diverticular disease was by Sigurdsson et al. on Icelandic and Danish patients.(60) The authors 
found an association of three introns variants in the genes ARHGAP15 (Rho GTPase-
activating protein 15) and COLQ (collagen-like tail subunit of asymmetric 
acetylcholinesterase) with diverticular disease and in FAM155A (family with sequence 
similarity 155A) with diverticulitis. Similarly, a more recent GWAS with 27,444 cases and 
382,284 controls, found 42 loci to be linked with diverticular disease with 39 of these loci being 
novel.(61) Interestingly, the genes in these associated loci have roles in immunity, extracellular 
matrix biology, cell adhesion, membrane transport and intestinal motility.  
The increased prevalence of diverticulosis and diverticular disease in the inherited conditions 
Ehlers-Danlos syndrome (EDS) type IV(62, 63), Willams-Beuren syndrome(64), and adult 
polycystic kidney disease(65-67) and possibly Marfan syndrome further support the role of 
heritability.(68)  
Ethnicity 
Ethnic differences also seem to exist within the spectrum of diverticular disease. For 
example, a large US screening population based colonoscopy study found different localization 
of diverticula depending on race and ethnicity. Among Caucasians the majority of diverticula 
(75%) were located in the sigmoid colon, while 11%, 6%, and 8% were located in the 
descending splenic, transverse and ascending or hepatic flexure, respectively. In contrast, 
while the sigmoid colon was still the most common location for diverticula in African 
Americans (64%), 20 % had diverticula localized to the ascending colon or hepatic flexure 
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and 8% and 7% located in descending colon or splenic flexure and transverse colon, 
respectively.(47)  
Further, ethnic and racial differences seem to affect the natural history of diverticular disease 
as well. US data from a study including 347 patients hospitalized with acute diverticulitis 
reported discrepant need for surgery, where African Americans required surgery more 
frequently than Hispanics and Caucasians.(69) The precise reasons for the ethnic/ racial 
discrepancies in localization and natural history are unclear.  
Similarly, in diverticular hemorrhage, while no gender predilection has been reported, race/ 
ethnicity disparities seem to exist. A recent report on trends in hospitalization in the USA 
between years 2000-2010 found that the incidence of diverticular disease has been highest in 
African Americans (34.4/100,000 in 2010) as well as for hospitalizations for diverticular 
bleeding compared to Caucasians.(41) Despite the predominantly left sided diverticular 
disease in the Western world, the most common site for diverticular hemorrhage is thought to 
be right-sided.(70, 71) Further, more extensive diverticulosis (pandiverticulosis vs. 
unilateral) seem to be associated with higher bleeding rates.(72) 
2.4.4.2 Lifestyle Risk Factors 
Diet  
Diet is described to play a role in diverticular disease but it is controversial whether this is 
true for diverticulosis per se. In 1969, Painter and Burkitt examined differences in diet, stool 
weight and stool transit times between UK and Uganda nationals and found that UK 
population had longer stool transit time and lower stool weights. These findings gave rise to 
the idea that fiber intake inversely correlated with the prevalence discrepancy between the 
two countries, where Uganda and UK had a low and high prevalence of diverticular disease, 
respectively.(8) Since the 1970’s, several UK and US epidemiological studies have confirmed 
that dietary fiber to be inversely linked with diverticular diseases.(73-75) Moreover, a 
vegetarian diet is reported to lower the risk of diverticular disease while high red meat 
consumption increases the risk of diverticulitis.(73, 76) 
However, the role of diet in diverticulosis though is controversial. Peery et al. found in a 
cross-sectional study low-fiber diet not to be associated with an increased risk of 
asymptomatic diverticulosis.(77) Similarly, a South Korean cross-sectional colonoscopy- 
based study found no difference between participants with and without diverticulosis 
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(predominantly right sided) and consumption and amount of vegetables, fermented vegetables 
(kimchi), fruits, and fruit juices intake.(52) 
Obesity 
During the past decades the frequency of diverticular disease has paralleled the steady 
increasing incidence of obesity in the Western world. Multiple large prospective cohort 
studies have found obesity to associate with diverticulitis, diverticular bleeding and 
diverticular disease requiring hospitalization.(11, 12, 78) In addition, a recent meta-analysis 
evaluating BMI and the risk of diverticular disease risk, included 6 cohort studies with a total 
of 28,915 cases and 1,636,777 participants in which a 28%, 31% and 20 % increase in the 
relative risk of diverticular disease, diverticulitis and diverticular disease complications, 
respectively, was noted per each 5 unit increase in BMI.(79)  
Conflicting results however exist on the association between obesity and diverticulosis. 
While Song and colleagues (52) and Strate et al.(13) did not find any association between 
obesity and diverticulosis, an Israeli study did.(80) 
Physical inactivity 
Several large population based studies have reported that high physical activity and/or 
vigorous exercise lowers the complication risk of diverticular disease including 
diverticulitis and diverticular bleeding.(12, 74, 81) Further, a recent systematic review and 
meta-analysis evaluating physical activity and risk of diverticular disease, included 5 adult 
prospective cohort studies with 2080 cases and in total 147,869 participants reported a 24% 
and 26% risk reduction of diverticular disease incidence and diverticulitis for the highest vs. 
lowest level of physical activity.(79)  
In contrast though, Peery et al.’s study including 2104 participants found no significant 
association between physical activity and diverticulosis.(77)  
Smoking 
Several prospective studies have found an increased incidence of symptomatic diverticular 
disease in smokers.(15, 16, 73, 82) A current systematic review and meta-analysis evaluating 
the relative risk of diverticular disease and complications of diverticular disease among current, 
former and ever smokers, included 5 prospective studies with 6076 cases of incident diverticular 
disease (diverticulosis and diverticulitis) out of 385,291 participants and 3 studies with 
1118 cases of complicated diverticular disease with abscesses or perforations out of 292, 965 
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patients exists.(83) The authors found a 36%, 17% and 29% increment of the relative risks of 
diverticular disease among current, former and ever smokers, respectively, and an increased 
risk for complicated diverticular disease.  
By contrast, in diverticulosis only few studies have suggested smoking to be associated with 
diverticulosis, but have been limited by loss of statistical significance when adjusted for other 
factors(52), (84) or by cross-sectional design.(84, 85) It is also noteworthy that before 
mentioned studies included Asian populations, which predominantly harbors right-sided 
diverticulosis.  
Alcohol 
Current data on alcohol as a risk factor for diverticular disease is conflicting. In a large Danish 
National patient registry study, a 3-fold risk of requiring hospitalization for diverticulitis was 
noted in patients admitted for alcoholism compared to the general population.(86) In contrast, 
two prospective population-based studies were unable to find an independent association 
between alcohol consumption and self-reported symptomatic diverticular disease or 
diverticular disease requiring hospitalization.(73, 82)  
In terms of diverticulosis though, a Lebanese cross-sectional study of 746 individuals 
undergoing screening colonoscopy and a Korean colonoscopy study found alcohol 
consumption to be associated with diverticulosis.(87),(52) However, recent systematic review 
and meta-analysis of 6 included studies with 53,644 subjects, found no association between 
alcohol consumption on a regular basis (OR=1.99; 95% CI 0.99–4.03) compared to subject 
who did not consume alcohol on a regular basis. While the overall number of subjects 
included had left sided predominance, four out of the 6 included studies were in Asian 
population and right-sided predominance in diverticula localization.(88) 
Medications 
Multiple studies have reported increased risk for complicated diverticular disease with 
opiates, corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs).(89-91) A 
recent meta-analysis with 11 included studies found an increased pooled OR of 3.4 for 
diverticular perforation and 12 studies with an increased pooled OR of 2.7 for diverticular 
bleeding with NSAID use.(92) The largest study, the US Health Professional Follow-Up 
Study (HPFS) cohort included 47,210 adult men, reported NSAID use to be independently 
associated with a 25% and 72% relative risk increment for developing diverticulitis and 
diverticular bleeding.(93) 
 12 
2.4.4.3 Environmental Risk Factors 
To date, studies on environmental factors, such as geographical variability, urbanization and 
crowded living, and their influence on risk for diverticular disease are sparse, conflicting and 
only assessed in adult populations.(39, 73, 94) An early small Greek study found high 
socioeconomic status (SES) and urbanization to be associated with diverticulosis.(39) But 
two more recent large population-based studies have found conflicting results. While one 
study found that residency in small cities, or rural areas increased the risk for uncomplicated 
diverticular disease and diverticular disease requiring hospitalization, respectively, when 
compared to urban living(94) another Swedish adult population-based study found thought 
that SES, housing or residence did not influence the rate future diverticular disease requiring 
hospital admission.(49)  
In the UK study a higher education level (higher secondary level and university degree vs. 
some secondary school) was noted to be protective against future hospitalizations from 
diverticular disease.(73) 
2.5 Pathophysiology 
The pathogenesis of diverticulosis is multifactorial and remains incompletely understood. 
Most studies have focused on structural features and alterations of the colonic wall with 
aging, abnormal motility, environmental factors and heritable factors. Their inter-relation in 
the pathogenesis of diverticulosis is unclear though.  
2.5.1 Structural Changes 
Both macroscopic and microscopic differences between colons with diverticulosis have been 
described in the literature. Macroscopically, a sigmoid colon with markedly thickened 
longitudinal and circular muscle layers and shortening of taeniae may be apparent. 
Microscopically, several studies support a colonic wall structural change. Specifically the 
increment in elastin deposition within the muscle fibers, which plays a role in the colonic 
elasticity, has been reported to possible contribute to the wall thickening.(95, 96) Whiteway 
et al. found in 25 surgical specimens of uncomplicated diverticular disease compared to 25 
controls, structurally normal appearing muscle cells but a difference in elastin deposition 
between cases and controls and between layers as well. In cases the taenia had twice as much 
of elastin deposition between myocytes and was noted to be in an aberrant pattern supporting 
contraction and are thought to be the reason for subsequent thickening of the circular muscle by 
means of contracting and shortening the taenia when compared to controls.(95) Further, age-
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related alterations in the smooth muscle with increased type III collagen in patients with 
diverticulosis compared to controls have been described to play a role.(97) In addition, an 
upregulation and increased concentration of a tissue inhibitor of metalloproteinases in 
diverticula-affected colons has been reported, possibly further explaining the increment 
elastin and collagen deposition.(98, 99)  
In addition, the increased prevalence of diverticulosis in patients with Ehlers-Danlos 
syndrome, Marfan’s syndrome and scleroderma, all connective tissue disorders, further 
support this postulated pathophysiologic mechanism.(68, 100, 101)  
2.5.2 Motility Changes 
Several explanatory motility disturbing pathogenic mechanisms in individuals with 
diverticulosis have been postulated over the years. Increased intraluminal pressures noted in 
patients with diverticulosis vs. controls (at rest, postprandial and post-neostigmine 
stimulation) have been reported and thought to contribute to altered motility.(48) (102) 
Adding to this notion, Painter et al. suggested that colonic contraction at the level of the 
haustral pleads could give rise to a series of discrete small bladders with consequently high 
intrasegmental pressures. He further suggested that the diverticula formation was linked to the 
low fiber diet increasing the intrasegmental pressures allowing the herniation. In terms of 
symptomatic diverticular disease though, specific aberrant motility patterns have been 
reported. For example, individuals with diverticulosis have been reported to have higher 
motility measurements when compared to asymptomatic patients (103), and higher 
magnitude and opposite direction waves in diverticula-affected colonic segments compared to 
diverticulosis-free segments, possibly explaining associated symptoms with diverticular 
disease.(104)  
Other postulated explanatory pathophysiological mechanisms, for the motility changes and 
symptoms in diverticular disease, include reduced number of the enteric pacemaker cells, 
interstitial cells of Cajal but preserved number myenteric and submucosal plexus neurons 
noted in those with diverticulosis vs. those without(105) and imbalance between the normal 
excitatory and inhibitory influences (increased cholinergic nerves and a decreased activity of 
non-adrenergic, non-cholinergic inhibitory nerves) in colons with diverticulosis vs. those 
without with resulting augmented tonicity in diverticula affected colons.(106) In addition, 
diverticulosis affected sigmoid segments were noted to have reduced magnitude of 
electronically stimulated contraction suggesting possible circular smooth muscle 
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dysfunction(107), possibly leading to both development of diverticula and bowel symptoms 
in diverticulosis-affected patients.  
2.5.3 Microbiome 
Dysbiosis has been postulated to play a role in pathogenesis of symptomatic diverticular 
disease.(108) Gut microbiome has been reported to change in response to diets as well as to 
environmental and lifestyle factors like obesity, tobacco and alcohol use, all of which have 
been implicated in diverticular disease.(109) In addition, some disease-specific variations in 
the gut microbiome have been reported. For example, in a mucosa adherent microbiota 
study of surgical specimens those with surgery for diverticulitis had more Bifidobacterium 
longum and B. animalis abundant compared to patients with IBD and colon cancer.(110)  
In addition, in SUDD patients a microbiome pattern with predominant Firmicutes strains over 
Bacteroidetes has been reported in fecal samples compared to controls.(111, 112) Further, 
patients with symptomatic diverticulosis have been found to have depletion of microbiota 
with anti-inflammatory properties such as Fusobacterium and Lactobacillaceae vs. 
asymptomatic patients in fecal samples.(113) Similarly, a recent study including patients 
undergoing elective colonoscopies for symptoms or due to family history of colon cancer, 
found that patients with diverticulosis had a higher amount of mucosal adherent 
Enterobacteriaceae compared to patients without diverticula but the symptomatology did 
not affect the amount of Enterobacteriaceae.(114) However, possible selection bias and 
heterogeneity in how the microbiome was measured, fecal samples vs. mucosa-associated 
microbiome, makes interpretation difficult.  
In terms of diverticulosis though, a recent screening colonoscopy study found no significant 
association between diverticulosis and mucosal adherent microbiota overall, or by the number 
or location of diverticula, suggestive of a nonsignificant role of mucosal adherent microbiome 
in the development of diverticulosis.(115)  
2.5.4 Inflammation 
Inflammation plays without a doubt a role in the acute setting of diverticulitis but also in the 
setting of chronic smoldering diverticulitis and SCAD where overt macro- and microscopic 
evidence of inflammation exist. However, the role of inflammation in diverticulosis and 
SUDD is unclear.  
In diverticulitis, an intradiverticular obstructing fecalith with low-grade inflammation, 
bacterial overgrowth and, mucosal breach with or without transmural extension leading to 
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perforation has been postulated as a pathogenic mechanism.(116) Histologically, features 
with mucosal lymphoid tissue hyperplasia with apical lymphoid aggregation of the involved 
diverticulum have been reported.(117) By the same token, as the name implies, SCAD is an 
inflammatory condition. SCAD is per definition a segmental colonic mucosal inflammation, 
macroscopically evident on endoscopy in the colonic segments harboring diverticula.(118) 
Histologically features are similar to IBD including chronic infiltration of lymphocytes, crypt 
abscesses, cryptitis and granulomas.(119)  
However, conflicting evidence exist on the pathophysiological role of inflammation in 
diverticulosis and symptomatic diverticular disease, namely SUDD.(120-124) For example, 
in the surgical specimens of patients who underwent sigmoid resection for symptomatic 
uncomplicated diverticular disease and not diverticulitis, Horgan et al. found evidence of 
chronic inflammation present both peri- and intradiverticularly. However, no correlation 
between the amount of inflammation and symptom intensity was noted.(122) On the other 
hand, Simpson and colleagues found evidence of post inflammatory damage to the enteric 
nervous system after recent diverticulitis associating with symptom persistence.(125)Further, 
Humes and colleagues found that chronic low-grade inflammation might alter motility and 
sensation by influencing the function of epithelial cells, smooth muscle and enteric nerves. 
(121) Similarly, Böttner et al. observed significant attenuation in serotonin transporter levels, 
which are a primary trigger of gut motility, in patients with history of acute 
diverticulitis.(126) 
In terms of the coexistence of symptomatic diverticulosis, diverticulosis per se and mucosal 
inflammation though published data is conflicting.(121, 127, 128) For example, patients with 
SUDD were found to have an increased expression of inflammatory modulators including 
TNF(127), galanin and tachykinins(121), and fecal calprotectin(129) comparison to 
controls.  Recently though, a study of 619 outpatients undergoing screening colonoscopy, 
found no evidence of mucosal inflammation measured as mRNA expression of tumor 
necrosis factor, CD4+ cells, CD8+ cells, and CD57+ cells in sigmoid biopsies of normal 
appearing mucosa in subjects with diverticulosis and/or abdominal pain and IBS compared to 
controls without diverticulosis.(130) Similar results were noted by Elli and colleagues in a 
smaller study.(128)  
2.6 Natural History 
Colonic diverticulosis is most commonly a benign and incidental finding. In fact, in most 
individuals affected with diverticulosis are and remain asymptomatic throughout their 
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lifespan. However, while only a small percentage actually develop diverticulitis, recurrence 
and associated complications and long-term sequela are possible. In a US retrospective study 
of patients with colonoscopy confirmed diverticulosis development of diverticulitis only 
occurred in 1-4 % of subjects during11 years follow up.(131) However, the risk of recurrent 
diverticulitis after an initial episode is significant. In a population-based study from the 
Olmstead County in Minnesota, USA the recurrence risk was observed to be 8% at 1 year, 17 
% and 22% at 5 and 10 years respectively. A second recurrence risk was even higher at 19%, 
44% and 55% at 1, 5 and 10 years, respectively. Further, being female and young posed an 
increased risk for any recurrence, while being male and elderly was associated with an 
increased risk of a recurrence complicated by obstruction, fistula, stricture, or peritonitis.(5) 
In addition, long-term sequela after the initial acute episode of diverticulitis is plausible. 
Apart from chronic symptoms such as abdominal pain and change in bowel habits, an 
increased 4- and 2-fold increased risk of new onset IBS and mood disorders after the initial 
diverticulitis event have been reported.(6) Moreover, lower health related quality of life in 
patients with chronic diverticular disease vs. controls is being increasingly recognized.(4) 
In contrary, SCAD tend to have a benign and self- limited clinical course (132) with no 
apparent increased risk of diverticulitis or colon cancer.(25) 
Diverticular hemorrhage is thought to differ from the other diverticular diseases in 
pathogenesis. Although not well understood, intimal thickening and medial thinning of the 
supplying vessel, vasa rectum, leading to weakening of the vessel, is thought play a 
role.(133) As the diverticulum forms the blood vessel is stretched with only the mucosal 
layer of the colon separating from the colonic lumen. When the vessel then ruptures mild to 
life-threatening hemorrhage may occur. The natural history studies on diverticular 
hemorrhage estimate that bleeding spontaneously stops in up to 80% of patients but with a 
30-day rebleeding rates and emergency surgery rates as high as 53% and 35%, 
respectively.(36, 70) 
2.7 Diagnosis 
2.7.1 Asymptomatic Diverticulosis 
Asymptomatic diverticulosis is commonly an incidental finding during colonoscopy or 
radiology imaging done with other indications and is the most common finding on 
colonoscopy.(7) 
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2.7.2 Symptomatic Diverticular Disease 
SUDD is clinically similar to IBS apart from the time criteria in the Rome criteria for 
diagnosis. Studies with aim to differentiate the symptom profiles in SUDD and IBS exist.(21, 
134) Purported differences include prolonged, less frequent, moderate to severe left lower 
quadrant (LLQ) abdominal pain (>24 hours), without relief by defecation, and family history 
of a first-degree relative with diverticular disease in those with SUDD vs. IBS.(21, 134) 
However the studies have been limited by selection bias hence leaving it unclear how 
symptoms in the community are related to diverticulosis.(21) Although laboratory tests 
should be normal a small case-control study reported fecal calprotectin to be higher in SUDD 
patients than in healthy controls and IBS patients.(129) 
Diverticulitis is usually diagnosed by history and physical exam. The classic presentation 
includes LLQ pain, fever and leukocytosis. However, despite a “classic” presentation clinical 
diagnosis can be inaccurate with a misdiagnosis rates as high as 34-68%.(135) Andeweg and 
colleagues investigated predictive factors to improve diagnostic accuracy and found 7 
features (age, number of episodes, LLQ symptom localization, pain on movement, absence 
of vomiting, LLQ tenderness, and elevated CRP > 50 mg/L) to be independent predictors of 
acute left-sided diverticulitis. A nomogram constructed from these predictors gave a 
diagnostic accuracy of 86%.(135) 
Additional diagnostic testing includes laboratory and radiologic tests. Suggestive findings 
on laboratory tests may be an elevated C reactive protein (CRP) and/or leukocytosis with or 
without left shift, indicating active inflammatory reaction and infection. Blood cultures may 
help to streamline antibiotic choice. Similarly, radiological evaluation can be helpful to 
diagnose, identify complications and guiding management. 
CT scans has a good sensitivity and specificity (up to 97%)(136), and include advantages 
such as readily availability, informative on disease severity and possible complications as 
well as being therapeutic in abscess drainage for example. Characteristic CT findings in 
diverticulitis include diverticula, pericolic fat stranding and segmental bowel wall 
thickening. Phlegmons, abscesses, fistulas and obstruction are findings suggestive of 
complicated diverticular disease. Ultrasound though is associated with low cost, great 
convenience and no ionizing radiation risk. However, although sensitivity and specificity is 
acceptable, at a reported 84-98% and 80-93 % respectively(137, 138), the operator 
dependency is a possible shortfall.(139) In contrast, MRI (magnetic resonance imaging) is 
radiation free, with excellent sensitivity and specificity of 100%(140) but is limited by limited 
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availability and potential motion artifact. 
 
Endoscopic diagnostic modalities such as colonoscopy, is the gold standard diagnostic test in 
for diverticulosis and diverticular hemorrhage. However, it is not currently recommended in 
the acute setting given concern for worsening diverticulitis or perforation. Albeit widely 
advocated, the recommendation is not based on RCTs. In fact, one study found no increased 
risk for perforation in the acute setting if air and water technique used.(141) Similarly, it is 
widely accepted and followed to pursuit a colonoscopy after the episode of diverticulitis. In 
fact, US guidelines recommend performing colonoscopies 6-8 weeks after the diverticulitis 
episode, if no prior screening colonoscopy has been done, with purpose to exclude 
colorectal cancer. This recommendation however is based on limited data. More recent 
studies are challenging the rationale and cost effectiveness. For example, a recent 
systematic review of studies in which patients with CT diagnosis of acute diverticulitis 
undergoing follow up colonoscopy found only a slightly higher pooled prevalence of 
colorectal cancer (2.1%) compared to a population of comparable age.(142)   
SCAD is diagnosed by endoscopic evidence of overt mucosal inflammation with erythema, 
friability and mucosal erosions, only within the diverticula-bearing colonic segment while 
sparing the rectum. Histology and clinical features are suggestive but not conclusive and 
are similar to IBD.(25) 
Diverticular hemorrhage usually presents as abrupt and painless and self-limited 
hematochezia. The initial diagnostic and therapeutic test is an urgent colonoscopy within 24 
hours of presentation.(143)  
2.8 Management 
2.8.1 Asymptomatic Diverticulosis 
While asymptomatic diverticulosis does not need any management, prevention of progression 
to symptomatic diverticular disease is recommended. Several guidelines currently 
recommend lifestyle modifications such as weight loss, exercise, increase high fiber diet and 
reduce red meat intake, avoid smoking and NSAIDs to prevent future risk of a first episode of 
diverticulitis.(144-147) 
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2.8.2 Symptomatic Diverticular Disease 
Treatment modalities for symptomatic diverticulosis can be divided into treatment options for 
SUDD, acute uncomplicated diverticulitis, complicated diverticulitis, SCAD and diverticular 
hemorrhage.  
SUDD: Different treatment options targeting postulated pathophysiological mechanisms such 
as diet, dysbiosis, inflammation and dysmotility have been considered in the management of 
SUDD. First, increased fiber intake has been recommended. However, this is based on old and 
observational uncontrolled data limited by high placebo response rates. Secondly, antibiotic 
treatment with Rifaximin (a poorly absorbable oral broad spectrum antibiotic covering Gram-
positive and negative bacteria including anerobes) is another option. In a meta-analysis of 4 
included RCTs, comparing the effect of Rifaximin combined with fiber vs. placebo on 
symptom relief in SUDD patients, Rifaximin was 29% more effective than placebo in 
symptomatic relief.(148) Similarly, probiotics have been studied. However, the results and 
potential benefits are inconclusive due to open-label design and heterogeneity in probiotic 
strains studied.(149-151) Thirdly, the anti-inflammatory agent,  mesalazine has been studied as 
a possible treatment for SUDD targeting the postulated inflammation. Three recent double 
blind placebo controlled studies support symtomatic relief from mesalazine when compared 
to placebo in patients with SUDD.(152-154) Lastly, anticholinergics and antispasmodics 
targeting featured hypermotility in diverticulosis have been used but no adequate controlled 
therapeutic trials have documented benefits.  
Diverticulitis: Treatment modalities for acute uncomplicated diverticulitis include outpatient 
vs. inpatient treatment. Inpatient treatment is typically reserved for patients with inability to 
tolerate oral intake, excessive emesis, fever or if lack of improvement on outpatient therapy or 
complicated features such as peritonitis. Traditionally, outpatient management including 
bowel rest, liquid diet and oral antibiotic treatment with colon bacteria coverage has symptom 
resolution in 94-97%. However, recently the standard antibiotic practice has been challenged. 
Evidence from a large multicenter RCT in Sweden and Iceland found when comparing 
antibiotic vs. no antibiotic treatment arms in 623 patients with acute uncomplicated left sided 
diverticulitis, no clinical difference in terms of symptoms, mean hospital stay, complications 
such as perforation or abscess, or recurrence needing hospital re-admission during the first 
year (16% in both arms).(155) Authors concluded that close observation without antibiotics 
may suffice as treatment in selected patients with uncomplicated diverticulitis. 
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Consequently, several guidelines and recommendations on diverticulitis management have 
changed. For example in Scandinavia, the Danish national guidelines do not recommend 
antibiotics in the management for uncomplicated diverticulitis.(146) In the US however, the 
AGA guidelines while still recommended the use of antibiotics it now advocates selective and 
not routine use of antibiotics in acute diverticulitis. While AGA guidelines acknowledged the 
findings of Chabbas et al. to be important, the concern for possible imbalance between 
comparative groups in terms of prior diverticulitis (44.8% in the antibiotic groups vs. 35.6% 
in the non-antibiotic group, p =0.02) resulted in more cautious recommendations.(147) 
In contrast, inpatient treatment includes intravenous antibiotics, fluids and bowel rest. In 
addition, complicated diverticular disease with pericolic or pelvic abscesses usually 
requires percutaneous drainage as additional treatment. Surgical drainage is otherwise 
reserved if refractory to percutaneous drainage. Surgical management is otherwise needed 
for perforated acute complicated diverticulitis but the optimal surgical strategy is still being 
debated.(156, 157) 
SCAD: Currently, there are no guidelines for its management, which is usually based on the 
administration of salicylates and antibiotics, with surgery being reserved for refractory cases.  
Diverticular Hemorrhage: An urgent colonoscopy within 24 hours of presentation, with 
rapid laxative bowel preparation (143) may achieve hemostasis. Existing endoscopic 
interventions include epinephrine injection therapy (1:10,000 dilution with saline),with 
thermal or mechanical therapy.(143) If high-risk clinical features and ongoing bleeding 
with refractory to hemodynamic resuscitation efforts are present then angiography should 
be considered If high-risk clinical features and ongoing bleeding with refractory to 
hemodynamic resuscitation efforts are present then angiography should be considered.(143) 
Surgery should be considered as last resort and partial colectomy is favored over subtotal 
colectomy whenever possible.(158) 
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3 AIMS OF THE THESIS 
 
 
Study I 
	
• To describe the prevalence of diverticulosis in the general population  
 
• To assess if diverticulosis is associated with abdominal discomfort or other 
gastrointestinal symptoms 
 
Study II 
	
• To examine if low-grade inflammation is present in the colon mucosa in individuals 
with diverticulosis 
 
Study III 
	
• To examine the role of environmental determinants in late adolescence and the risk 
of diverticular disease requiring hospitalization 
 
Study IV 
	
• To examine if late adolescent lifestyle factors influence the risk of diverticular 
disease requiring hospitalization 
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4 METHODS 
Table 1. Overview of study designs, number of participants, data collection, main 
outcome variables and statistical analysis methods. 
Stud
y 
Study 
Design 
Number of 
Participants 
Data 
collection 
Main outcome  Analysis 
Methods 
I Cross 
sectional 
742 Questionnaires 
Colonoscopy 
Diverticulosis 
Gastrointestinal 
symptoms 
Logistic 
regression 
II Nested 
Case 
Control 
254 Questionnaires 
Histopathology 
 
Mucosal and 
serological 
inflammatory 
markers 
Gastrointestinal 
symptoms 
Logistic and 
Linear 
Regression 
III Cohort 45 952 Questionnaires 
Register data 
Physical 
assessment 
Diverticular 
disease 
requiring 
hospitalization 
Cox 
Regression 
IV Cohort 43,772 Questionnaires 
Register data 
 
Diverticular 
disease 
requiring 
hospitalization 
Cox 
Regression 
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4.1 Study design and Study populations 
4.1.1 The PopCol Study Population 
Papers I and II were both part of the larger PopCol study. The aim of the PopCol 
study was to survey colonic pathology and its association with gastrointestinal 
symptoms in a normal population and was carried out between 2000 and 2006. The 
design is a population-based cross-sectional study in which the study population was 
selected by using the official Swedish National Population Register. A random sample 
of 3556 Swedish born individuals, aged 18 to 70 years, out of the existing 38,646 
inhabitants of the parishes Katarina and Sofia (parishes surrounding Ersta Hospital 
where the study took place) in Södermalm, Stockholm, Sweden in the year 2000, were 
selected and contacted. The official Swedish National Population Register includes all 
inhabitants without exception. Individuals not born in Sweden were excluded a priori.  
The study population was representative of the whole native Swedish adult population 
(11% born abroad were excluded) except in gender. A unique identification number 
was given to each individual. The original study population received the validated 
Abdominal Symptom Questionnaire (ASQ) with questions on troublesome 
gastrointestinal symptoms over the past three months by mail.(159) While all 
responders were telephoned and scheduled for a preparation hospital visit with a 
gastroenterologist if agreeable, the non-responders underwent structured interview 
over the phone. During the gastroenterology visit all the participants completed an 
extended and validated questionnaires (ASQ, Rome II Modular Questionnaire and 
Hospital Anxiety Depression Scale (HADS)) and underwent blood and fecal sample 
collection. The colonoscopy procedure was offered during this visit.  
In total, 2293 were questionnaire responders, of which 1244 out of 1673 were reached 
by telephone and scheduled for a gastroenterologist consultation. Overall, 745 out of 
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1244 participants (426 women and 319 men) accepted and consented to proceed with 
subsequent ileo-colonoscopy. See flowchart in Figure 2. 
Ileo-colonoscopy with biopsies 
Seven experienced endoscopists all colonoscopies were performed in Ersta Hospital 
between June 2002 and October 2006. Bowel preparation for the colonoscopy 
procedure included bowel cleansing with 45 ml Phosphoral taken orally twice within 
4-hour interval and clear liquid diet the day prior to the colonoscopy. All colonoscopies 
followed Swedish standard of care and included administration of sedation and 
analgesics (inhaled nitric oxide, intravenous midazolam and/or alfentanyl) on an as 
needed basis. Colonic biopsy sampling from all colonic segments (cecum, transverse, 
sigmoid and rectum) using standard endoscopic forceps (Boston Scientific, Boston, 
USA) was performed in all participants. The endoscopists were blinded to 
participants’ past medical history and questionnaires results but aware of the study’s 
general aims and protocol. All adverse events were recorded. The location and 
presence of diverticula was diagnosed and recorded at time of colonoscopy. 
Paper II is based on a nested case-control study derived from the PopCol study 
population. Cases were those with diverticulosis diagnosed during the colonoscopy. 
The cases were matched 1:1 to gender and age (+/- 2 years) with controls (those 
without diverticulosis) from the remaining 615 participants who underwent a 
colonoscopy. Missing data on localization of diverticula left a total of 127 cases and 
127 controls for analysis. Participants with inflammatory bowel disease and/or 
microscopic colitis were excluded a priori. See flowchart in Figure 2. 
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Figure 2. Flow chart for paper I and II 
4.1.2 The Swedish Conscript Cohort 
Paper III and IV are both based on the nationwide, population-based cohort study of 
49,321 male Swedish conscripts, age 18-20 conducted during 1969-1970. During the 
time of the study conscription was compulsory in Sweden. Exemption only occurred 
in 2-3% of men, mainly due to severe disabilities or diseases. Data was prospectively 
collected with extensive psychological and physical examinations  including face-to-
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face interviews, questionnaires on lifestyle behaviors, alcohol, smoking and use of 
recreational drug consumption and self-rated health at times of conscription.  
In paper III, 46,171 men out of the total 49,321 men had complete data on 
environmental and adjusting lifestyle factors of interest. See flowchart in Figure 3. 
In paper IV, 43,772 out of the total 49,321 men had complete data on all the lifestyle 
factors of interest. Loss to follow up during the study period included 421 emigrations 
and 3019 deaths before 1987. Flowchart can be seen in attached paper IV. 
 
Figure 3. Flowchart paper III. 
4.2 Outcomes of Diverticular Disease 
4.2.1 Paper I and II 
The outcome of interest was the presence of Diverticulosis, which was diagnosed 
during the colonoscopy. 
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4.2.2 Paper III and IV 
The outcome of interest was Symptomatic Diverticular Disease requiring 
hospitalization. 
The dataset from the Swedish Conscript Cohort study was linked to the Swedish NPR 
by using the unique Personal Identity Number (PIN), which all Swedish citizens 
obtain after birth or immigration. To identify the primary discharge diagnoses 
(outcome of interest) in the NPR the following International Classification of 
Diseases (ICD) codes for Diverticular Disease (ICD-8: 562.10-11; ICD-9: 562.10-13; 
ICD-10: K57.2-5, K57.8-9) were used. The NPR includes all information on 
hospitalization including discharge diagnoses classified into ICD codes, dates of 
hospital admission and discharges. While the NPR was established in1964, 
nationwide coverage was not obtained until 1987. Approximately 99% of all somatic 
discharge diagnoses are covered in the NPR and the validity of hospital discharge 
diagnoses is between 85-95% depending on diagnosis. In Sweden, ICD-10 codes have 
been used since 1997 and ICD codes 8 and 9 since1969 to 1996. Secondary discharge 
diagnoses in NPR of gastrointestinal hemorrhage (ICD-8: 578.9; ICD-9: 578.9; ICD-
10: K92.2) were excluded a priori to minimize the risk for misclassification of 
diverticular bleeding being included in the outcome of interest.  
4.3 Variables/ Covariates 
4.3.1 Paper I and II 
Background variables were derived from the face-to-face interview and examination 
during the gastroenterology visit and at the time of colonoscopy and verified using the 
PIN number and with the electronic medical records. These included age, gender, 
body mass index (BMI) (defined as weight in kilograms divided by the square of the 
height in meters (kg/m2), smoking ((paper II only) obtained at the time of 
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gastroenterology consultation and defined as non- or current smoker) and the use of 
laxatives and antibiotics. Recent antibiotic use was defined as any antibiotic use 3 
months prior to visit or colonoscopy and was in addition to self- report at the 
gastroenterology consultation interview also verified from electronic medical record 
using ATC codes.  
Gastrointestinal symptoms were obtained from the validated Rome II Modular 
questionnaire and included; abdominal pain or discomfort (located anywhere in the 
abdomen for at least 3 weeks, at least one day in each week, in the past 3 months); 
mushy stools; high frequency defecation (> 3 bowel movements a day); lumpy stools; 
low frequency defecation (one bowel movement less than every three days); bloating, 
urgency: straining during defecation: sensation of incomplete bowel movement; 
passage of mucus during defecation and fecal incontinence. 
Irritable Bowel Syndrome (IBS) and IBS subtype diagnoses were derived from the 
Rome II Modular questionnaire using the Rome II symptom-based criteria. IBS was 
defined as having abdominal pain or discomfort for at least 3 weeks (at least one day 
in each week) in the past 3 months with at least two out of three of the following: pain 
or discomfort improved or relieved after a bowel movement, onset of pain or 
discomfort associated with a change in the usual number of bowel movements, or onset 
of pain or discomfort associated with a change in stool consistency. Similarly, IBS-
Diarrhea (IBS-D) was defined as having IBS and reporting loose, mushy or watery 
stools but not hard or lumpy stools at least 25% of the time for the last three months 
and IBS-Constipation (IBS-C) as having IBS and reporting hard or lumpy stools but 
not loose, mushy or watery stools at least 25% of the time in the last 3 months.(160, 
161) 
Localization of abdominal pain or discomfort (paper I only) was derived from the 
ASQ and defined as presence of “trouble- some“ abdominal pain/ discomfort in the 
preceding 3 months specified to epigastrium, periumbilical, suprapubic area, right 
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quadrant, left quadrant or the whole abdomen. Left lower quadrant included the 
suprapubic and left quadrant areas. Separate analysis of all localizations was 
performed. 
Anxiety, depression (paper I only) diagnoses were made if the HADS score for 
respective condition was 8 or above.(162) 
Self-rated health was assessed with the question: “In general, would you say your 
health is: excellent, very good, good, fair or poor”. 
Inflammatory Bowel Disease (IBD) and Microscopic Colitis diagnoses were either 
established (by past medical history of Crohn’s disease, ulcerative colitis or 
microscopic colitis obtained from the questionnaires, gastroenterology visit or at the 
time of colonoscopy) or newly diagnosed (by histopathology review by expert 
pathologist of the colonic biopsies obtained during the colonoscopy).  
History of diverticulitis by self- report was derived from questionnaires and the face-
to-face interview at time of the gastroenterology visit. 
4.3.2 Paper II 
Serological and colonic mucosal inflammation was assessed by serum levels of C 
Reactive Protein (CRP) collected during the gastroenterology visit and histological 
examination of the colonic biopsies obtained during the colonoscopy. The biopsies 
were routinely processed with formalin-fixed paraffin-embedded tissue blocks, 
sectioned and stained with Hematoxylin & Eosin (H&E) and stored. For this study, in 
collaboration with Professor Marjorie M. Walker, the biopsy slides belonging to the 
study population in Study II were shipped to the Hunter Area Pathology Service 
Department at the University of Newcastle, NSW, Australia, for histological analysis. 
Two GI pathologists blinded to the case-control status performed the analysis and 
concordance of pathology between pathologists was calculated. 
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Assessment of the H&E stained biopsies included the presence or absence of markers 
of histological inflammation, specifically, intact surface epithelium, mucin depletion, 
Paneth cell metaplasia, cryptitis, crypt abscesses, apoptosis of epithelium, normal 
architecture/ crypt branching, intact chronic inflammatory gradient (no expansion of 
chronic inflammatory cells from base to surface), basal plasmacytosis and 
granulomas. Further, the number of lymphoid aggregates, follicles and neutrophils 
were counted in the lamina propria, and intraepithelial lymphocytes were counted/ 100 
colonocytes. Other present pathology was noted and recorded.  
4.3.3 Paper III and IV 
Environmental and lifestyle factors were derived from the questionnaires completed 
by all conscripts at time of conscription. The questionnaires included questions on 
upbringing conditions such as residence, living conditions, social background, school 
and personal relationships and parents’ marital status and social groups as well as 
questions on lifestyle behaviors such as alcohol, tobacco, and recreational and narcotic 
drug use. The initial assessment at time of conscription also included rigorous physical 
and psychological assessments. 
Environmental factors (Study III only) 
Residency was derived from the conscripts’ zip code at time of conscription and 
defined as the region of upbringing and geographical location of residency at time of 
conscription. As defined by Statistics Sweden (a governmental statistical department 
established in 1858 with accurate validated information) the geographical residency 
was classified into categories dependent on the number of inhabitants: Large cities 
were areas with a population of >200,000; large towns with >50 000 inhabitants, 
small towns with <50 000 inhabitants, and rural localities were areas with 50–199 
inhabitants in a contiguous built-up area with no more than 150 meters between 
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houses. The fifth category, abroad, included conscripts who had been living abroad prior 
to time of conscription. 
Living conditions was derived from the questionnaires and included where the 
conscript lived most of the time; both parents, mother, father or with another person, and 
whether the living condition was crowded or non-crowded. As defined by the Swedish 
National Board of Housing, Building and Planning during the years 1965- 1974  
(corresponding to the study period when data was prospectively collected) crowded 
living was present if >2 individuals lived per room, excluding kitchen, bathroom and 
living room. 
Parental marital status was derived from the questionnaires and answered as divorced 
or not divorced. 
Parental socioeconomic status (SES) was based on the paternal socioeconomic status, 
which was categorized in to 7 categories dependent on the occupation of the head of 
the household (father) when the conscripts were age10 (years 1959-1960). The 7 SES 
categories included (1) unskilled workers, (2) skilled workers, (3) assistant non-
manual employees, (4) non-manual employees at intermediate level, (5) non-manual 
employees at higher level, (6) farmers and (7) unclassified, which were those fathers 
not classified into a socioeconomic group. The highest SES belonged to fathers’ who 
were non-manual employees at higher levels. The paternal SES data was derived 
from the Statistics Sweden Register linked through the conscripts’ PIN obtained at 
birth. 
Lifestyle factors (Study III and IV) 
BMI was calculated from the weight and height obtained at the physical exam at time 
of conscription (kg/m2). BMI was categorized into 4 categories: underweight (<18.5 
kg/m2), low normal (18.5-<22.5 kg/m2), high normal (22.5-<25 kg/m2) and 
overweight and obese (⩾25kg/m2). For study IV, the reference category was the low 
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normal category (BMI 18.5-<22.5 kg/ m2). Given the low number of obese conscripts 
(BMI ⩾30) men (0.8%) the obese category was combined with overweight category 
into one category. 
Cardiovascular fitness was derived from a stanine scale, which was obtained from the 
conscripts’ maximum work capacity on an ergometer cycle divided by the body 
weight. The stanine scale ranged from 1 to 9, where a higher score indicated a better 
result. (163) 
Use of recreational drugs (other than alcohol and tobacco) was derived from the 
questionnaires at time of conscription and was defined as present if the conscript had 
ever tried or was actively using any recreational drug. 
Smoking status and amount was derived from the questionnaires completed at time of 
conscription and classified into 5 categories: absent, 1–5 cigarettes per day, 6–10 
cigarettes per day, 11–20 cigarettes per day or > 20 cigarettes per day. 
Alcohol consumption derived from the questionnaires was defined per weekly amount 
and categorized to; absent, 1–100 g of pure alcohol per week, 101–250 g per week or 
> 250 g per week. 
Risky alcohol use was defined as present if apprehension for drunkenness and/or being 
drunk often and use of alcohol to alleviate a hangover was reported. 
4.4 Statistical analysis 
All statistical analyses were performed in STATA (versions 11.0, 13.1 or 14. 
StataCorp, Texas). Results were considered significant when the two-sided p value 
was < 0.05. 
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4.4.1 Logistic and Linear regression (Paper I and II) 
To assess the differences in dichotomous (present or absent) background variables, 
IBS and gastrointestinal symptoms between participants with and without diverticulosis 
logistic regression was used. These were presented as crude and multivariate analysis by 
adjusting for age and gender. In paper I, an interaction analysis was performed to 
evaluate interaction between diverticulosis and antibiotic use and gastrointestinal 
symptoms with an interaction term diverticulosis *use of antibiotics. 
In paper II, the nested case control study, gender and age (+/-2 years) matching was 
done with the purpose to enhance comparison between cases and controls and reduce 
variability and to ultimately use McNemars’ analysis to evaluate association between 
diverticulosis and inflammatory markers. However, due to the unexpected and 
unfortunate loss of multiple slides during shipping, loss of multiple pairs occurred 
explaining the reasoning for choosing unpaired statistical analysis (logistic and linear 
regression adjusted for age and gender) to preserve sample power. Hence, in paper II 
diverticulosis status and symptom status was used as explanatory variables for 
practical reasons, and logistic regression or linear regression with bootstrap with X 
repetitions were used depending on whether the tested variable was dichotomous 
(presence of histopathology finding) or continuous (number of cells). 
All analyses were age and gender adjusted. 
4.4.2 Cox Regression (Paper III and IV) 
To calculate the association between lifestyle factors and symptomatic diverticular 
disease requiring hospitalization, cox regression analysis was done. Hazard ratios 
(HR) were used to present estimates. The data was presented in a crude model per 
lifestyle factors and as multivariate model including all lifestyle factors. The lifestyle 
factors included in the analysis were: BMI (continuous and categorical), 
cardiovascular fitness, smoking, use of recreational drugs, alcohol consumption and 
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risky alcohol use were calculated. The multivariate models BMI was presented as both 
a continuous and categorical variable. Proportionality testing using Schoenfeld 
residuals was done in all models, with no evidence of violation. Risk time was defined 
as the time from conscription until the time of death of any cause, emigration, the first 
registered discharge diagnosis of symptomatic diverticular disease or the end of the 
follow-up period (31 December, 2009), whichever came first. The men were 
considered lost to follow-up after emigration but contributed with the time until 
emigration to the analysis. 
4.5 Ethical considerations 
For studies I and II the ethical approval was obtained from the regional ethics 
committee at Karolinska Institutet (Forskningskommitte Syd, DNR 394/01). 
For study III and IV, the regional ethics committee at Karolinska Institutet (DNR 
2004/5:9 – 639/5) approved the studies. Due to the character of the database and the 
data being anonymous, no written informed consent was needed. 
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5 RESULTS 
Below is a summary of results. For the detailed results please see the appended 
papers. 
5.1 Paper I  
Prevalence and localization of diverticulosis 
During the study period a total of 745 participants underwent ileo-colonoscopies, but 
missing data on the presence of diverticulosis left 742 for analysis. Out of the 742 
participants 130 had diverticulosis (17.5%, 95% CI: 14.95-20.4). The prevalence of 
diverticulosis increased with age as seen in Figure 5 and was similar among gender 
(men=18.6%, women=16.7%). Consequently age differed among those with and 
without diverticulosis (mean age=60, range 37-71 years vs. mean age 51, range 19-70 
years, respectively, p< 0.001). Overall, older participants (>60 years of age) reported 
less gastrointestinal symptoms than younger participants. 
Diverticula was localized in the sigmoid colon in all affected participants while the 
cecum, ascending, flexures with transverse colon and descending colon were only 
involved in 3.2%, 4.0%, 13.6% and 12.7%, respectively. 
Diverticulosis and gastrointestinal symptoms, IBS and IBS subtypes 
Missing data on gastrointestinal symptoms and BMI, left a total of 122 and 577 
participants with and without diverticulosis for analysis of gastrointestinal symptoms, 
respectively. Overall, results were noticeable for a significant association between the 
presence of diverticulosis and diarrhea symptoms, namely, mushy and high frequency 
stools (OR: 1.88, 95%CI: 1.20-2.96, p=0.006; OR: 2.02, 95%CI: 1.11-3.65, p=0.02, 
respectively) and urgency and passage of mucous (OR: 1.64, 95%CI: 1.02-2.63 
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p=0.04; OR: 2.26, 95%CI: 1.08-4.72, p=0.03, respectively) in all participants 
regardless of age.   
Age stratification further showed that in those older than 60 years of age vs. those 60 
years and younger, diverticulosis was significantly associated with abdominal pain  
(OR: 2.10, 95%CI: 1.01-4.37, p=0.047) and IBS-D (OR: 9.55, 95%CI: 1.08-84.08, 
p=0.04) in addition to diarrhea symptoms. Similar results were noted when excluding 
participants with colitis and recent antibiotic exposure.  
In terms of anxiety, depression or self-rated health there was no difference among 
participants with diverticulosis vs. those without or when age was stratified. 
In the analysis of localization of abdominal pain using the ASQ, missing data on pain 
localization left 703 participants for analysis. Overall, pain was reported by 55 of 122 
participants with diverticulosis and 286 of 581 participants without and a trend was 
noted for left lower quadrant (LLQ) localization of the abdominal pain/discomfort 
(OR: 1.83; 95%CI: 0.92-3.64, p=0.09). However, when age stratified, the abdominal 
pain was significantly associated to the LLQ localization in participants older than age 
60 years with diverticulosis vs. those without (OR: 6.78, 95%CI: 1.80-25.56, 
p=0.005). 
Lastly, recent antibiotic exposure was present in 21 out of 127 (16.5%) in those with 
diverticulosis compared to 70 out of 610 (11.5%) in those without diverticulosis. 
Antibiotic exposure was significantly higher in those older than age 60 than in those 
age 60 years or younger (14.1% (95%CI: 13.8-14.4) vs. 11.5% (95%CI: 11.4-11.6), 
p<0.001, respectively), regardless of diverticulosis status. Results of the interaction 
analysis between diverticulosis and recent antibiotic use on GI symptoms showed a 
positive interaction effect between the presence of diverticulosis and recent antibiotic 
use indicating that participants with diverticulosis and recent antibiotic use were more 
symptomatic, namely GI symptoms, than those with diverticulosis without recent 
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antibiotic use, or participants without diverticulosis with recent antibiotic use.(Figure 6) 
The GI symptoms mushy stools, high frequency stools and urgency were the specific 
symptoms associated with a positive interaction. 
 
Figure 4. Prevalence of diverticulosis per age group presented as a percentage. 
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Figure 5. Adjusted OR with 95% CI for each gastrointestinal symptom evaluating 
the interaction of antibiotics and diverticulosis in all 4 different groups. The 
reference group was “no antibiotics, no diverticulosis”, with an OR of 1.00. The 
other groups were as follows: “recent antibiotics, positive diverticulosis”, “recent 
antibiotics, no diverticulosis”, “no antibiotics, positive diverticulosis”. 
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5.2 Paper II 
 
Overview 
A total of 242 participants were included in this 1:1 nested case control study. Age 
was similar among cases and controls (60.8 years (7.5) vs. 60.7 years (7.4), p=0.92) 
and the gender distribution was equal (45.7% males, p=1.00). Similarly, background 
variables such as BMI (p=0.71), smoking (p=0.34) or recent antibiotic exposure 
(p=0.68) were similar between cases and controls. Cases with diverticulosis differed 
from controls in terms of reported symptoms such as mushy and high frequency stools 
and abdominal pain (p=0.01, p=0.03, p=0.04, respectively). GI symptoms were 
otherwise similar among the groups. As previously reported in Paper I all participants 
with diverticulosis had sigmoid colon involvement while only 8 (6.3%) had both the 
right and left colon affected. 
Diverticulosis, Symptomatic Diverticulosis and Inflammation 
Overall, median CRP levels were similar between cases and controls (1.05 (0.3, 2.7) 
vs. 0.8 (0.4, 2.2), p=0.53). Missing data on mucosal inflammatory markers on 
histology left a total of 170-215 participants for analysis. Mucosal inflammatory 
markers such as surface epithelium and chronic inflammatory gradient were intact in 
all participants’ and basal plasmacytosis, granulomas and mucin depletion were absent 
in all samples. Logistic and linear regression analysis models showed no association 
between mucosal inflammatory cells and diverticulosis throughout the colonic 
segments on the histology analysis. Only a trend of increased numbers of cecal 
lymphoid aggregates in cases vs. controls (p=0.07) was noted. 
In the sub-analysis evaluating the association between symptomatic diverticulosis and 
serological and mucosal inflammation, missing data on GI symptoms left 241 
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participants for analysis, of which 45 (38%) cases and 30 (25%) controls reported 
diarrhea and 34 (29%) cases and 21 (17%) controls reported abdominal pain.  
Cases with diarrhea were similar in background variables compared to asymptomatic 
controls except for recent antibiotic use, which was two-fold more likely in cases with 
diarrhea compared to asymptomatic controls (OR 2.50, 95% CI: 1.01, 6.15, p=0.047). 
Median CRP levels (p=0.23) and mucosal inflammatory markers were similar among 
symptomatic cases, asymptomatic cases and symptomatic controls when compared to 
asymptomatic controls. 
Cases with abdominal pain had a trend to be active smokers (OR 2.51, 95%CI: 0.93, 
6.72, p=0.068) but were otherwise similar when compared to asymptomatic controls. 
Median CRP levels did not differ significantly among cases with abdominal pain and 
asymptomatic controls (p=0.19). Similarly, no association between mucosal 
inflammatory markers and cases with abdominal pain compared to asymptomatic controls 
was noted except for a significantly less number of rectal lymphoid aggregates present 
than asymptomatic controls (p=0.022). Interestingly though controls with abdominal 
pain were 16 times more likely to have cryptitis present in the transverse colon in 
comparison to asymptomatic controls (OR 16.12, 95%CI: 1.31-197.96, p=0.03); an 
analysis adjusted for smoking and recent antibiotic exposure gave similar results (OR 
17.38, 95%CI: 1.29-233.24, p=0.03).  
 
5.3 Paper III 
Overview 
During the study period 3150 out of 49,321 men had incomplete data for any of the 
exposure variables and leaving 46,171 observations for analysis. The mean follow-up 
time was 37.9 years (SD ± 4.7, range 0-39), or 1,749,037 person-years. During the 
follow up period a total of 433 men (0.9%) required hospitalization for symptomatic 
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diverticular disease, 442 men emigrated and 3173 men died. Mean time to the first 
primary diagnosis of symptomatic diverticular disease requiring hospitalization was 
29.9 years (SD ± 6.3, range 2-39).  
In terms of geographical location of residence most conscripts were brought up in 
rural areas (38.8%) and small towns (29.8%). The most common type of living 
conditions was non-crowded (79.4%) and most conscripts lived with both parents 
(89.6%) at time of conscription. The most common conscripts’ paternal occupations were of 
unskilled and skilled worker category (33. 2 % and 21.4 %, respectively) while only 11.1% were 
farmers.  Parental divorce was only reported by 4728 (10.2%) of all conscripts.  
Environmental Factors and Risk of Symptomatic Diverticular Disease requiring 
hospital admissions 
The only environmental factors found to be associated with the risk of hospital 
admission for symptomatic diverticular disease was parental divorce. Parental divorce 
was independently associated with a 49% increased risk of hospitalization for 
symptomatic diverticular disease later in life when compared to those with married 
parents (HR 1.49, 95%CI: 1.02-2.17, p=0.04). No other environmental factor was 
associated with hospital admissions for symptomatic diverticular disease. 
5.4 Paper IV 
Overview 
In total, the study included 49,321 men and incomplete data on any of the exposure 
variable left 43,772 observations for analysis. Emigration and death accounted for 421 
and 3019 losses to follow up, respectively, during the study period. The mean follow-
up time was 37.8 years (SD +/- 4.8 years; range, 0– 39 years), or 1,657,659 person-
years. The mean time to the first primary diagnosis of symptomatic diverticular 
disease requiring hospitalization was 30.0 years (SD, +/- 6.26 years; range, 2– 39 
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years) and was received by a total of 444 men during the follow up period. 
Readmission for the same diagnosis occurred in 184 out of 444. 
In terms of lifetime factors the mean BMI at conscription was 21.0 kg/m2 (SD: 2.6 
kg/m2), equivalent of normal BMI range. Very few (0.8%) conscripts classified as 
obese (BMI >30). Alcohol consumption was common (70.7%) but in adequate 
amount of less than 100 g/wk. At the time of conscription, 58.6% were smokers and 
11.6% reported ever having used recreational drugs. 
Lifestyle Factors and Risk of Diverticular Disease 
First, BMI was independently associated with an increased risk of diverticular disease 
as a continuous variable by 9% per unit increment in BMI (HR:  1.09, p< 0.001) and 
as a categorical variable. A 2- fold increased risk for developing symptomatic 
diverticular disease was noted in overweight and obese conscripts (BMI >25) (HR: 
2.02, p< 0.001) when compared to conscripts with low normal BMI (Figure 9). 
Similarly, smokers was had a significantly higher risk of developing symptomatic 
diverticular disease compared to nonsmokers, across all smoking categories except for 
the highest. Risky alcohol use was also independently associated with a 43% 
increased risk of developing symptomatic diverticular disease (HR: 1.43, p= 0.01). In 
contrast, higher cardiovascular fitness independently reduced the risk of development 
of diverticular disease (HR: 0.94, p= 0.02) compared to lower cardiovascular fitness, 
Alcohol consumption per se and the use of recreational drugs were not associated with 
increased risk of development of symptomatic diverticular disease (p=0.19, p=0.76; 
respectively). 
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Figure 6. Kaplan-Meier curve for the development of symptomatic diverticular disease requiring 
hospitalization per BMI category 
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6 METHODOLOGICAL CONSIDERATIONS   
6.1 Study design 
All four studies in this thesis are observational. The study in Paper I is cross-
sectional, which unavoidably inherits certain limitations per design. One limitation is 
the lack of consideration of temporal aspects. Hence, while inference on associations 
between outcome of interest and variables can be made, no inference on causality can 
be made. The other limitations include possible selection bias, decrease external 
validity as well as the presence of possible confounding factors affecting the 
associations.(164)  
Paper II is a nested case-control study from the same PopCol study population in 
Study I. In our study, we identified subjects by the outcome of interest 
(diverticulosis) at the initiation. Generally, methodological considerations for case 
control studies include the importance of study population selection to minimize 
selection bias and improve generalizability.(165) Our study population was obtained 
from the PopCol study population, which is a representative sample of a Swedish 
born urban population, minimizing selection bias and improving generalizability to 
Swedish urban populations. Other shortfalls of case control studies include 
susceptibility to recall bias or information bias, all of which are addressed 
below.(165) Another important thing to recognize is that case –control studies 
provides approximate estimates of relative risk, which may or may not be 
inaccurate, and not valid estimates of risks or odds.(165) 
Papers III and IV are retrospective cohort studies with prospectively collected 
exposure data. All individuals were disease-free when the exposure status was 
established correlating with the beginning of the observation period. The time of 
exposure was measured at initiation of the study, and the outcome of interest was 
studied along the follow up period, with other words a single baseline design. The 
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difference between exposed and unexposed groups was then calculated. Although is a 
good approach when assessing multiple risk factors, one shortfall is that distribution 
of the risk factors cannot be controlled, possibly leading to different numbers in the 
factor and nonfactor groups.(164) Another is the withdrawals by loss to follow up, 
but in our study this was very low (<1%) given the existing mandatory conscription 
law in Sweden at time of the study and access to register data using the PIN. Lastly, 
residual confounding factors are an important threat, which I address below.  
 
In papers III and IV given the single baseline design with exposure variables only 
collected at baseline, making inference on the effect of modifications of lifestyle and 
environmental factors over time on the outcome of diverticular disease requiring 
hospitalization is not possible. 
6.2 Bias 
All research is subject to the risk of error. One differs between random errors, which 
can usually be dealt with increasing the sample size of a studied population, and 
systematic errors (bias). Bias must be considered and dealt with either in the design 
of the study, or in its interpretation and include selection bias, information bias and 
confounding.(165)  
6.2.1 Selection bias 
Selection bias arise when the selection of the study population, either by selection 
procedures or factors, influence the inclusion and/or exclusions of study 
participants.(165)   
The PopCol-population in papers I and II is a random sample from the adjacent 
parishes in Stockholm, which minimizes selection bias and improves generalizability 
as participants are less likely biased by medical attention or secondary gain behavior. 
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Further, it has a high participation rate and a wide age range. The voluntary 
participation without financial compensation further helped minimizing any potential 
risk of selection bias. In addition, an earlier study of the PopCol population showed in 
a comparative analysis similarity in measured variables between questionnaire 
responders and non-responders, suggesting good generalizability of the general 
population.(166) Similarly, we performed a comparative analysis between the 
colonoscopy participants and the non-colonoscopy ASQ responders and although no 
difference in gender or education was noted, those undergoing colonoscopy were 
older and reported more gastrointestinal symptoms (abdominal pain), reflecting 
possible response bias. However, the main finding was the association between 
diverticulosis and diarrhea, and hence unlikely to have impacted the results. Further, 
the older participants were less symptomatic overall. Hence, although an 
overestimation in the younger participants is possible, diverticulosis was very rare in 
the younger individuals. Lastly, the underrepresentation of younger participants in 
study I, especially men despite the random sampling process of participants need to be 
recognized. A noticeable lower participation rate was noted at all levels including 
response rate of the mail questionnaire and the nonresponse analysis. Although the 
precise reason is unclear, one may speculate that younger individuals are less likely to 
respond to questionnaires due to frequent residency changes compared to the older 
participants.  
 
In paper II cases from study I was age (+/-2 years) and gender matched with controls 
from the same population. This nested case control study was performed to optimize 
comparisons between cases and controls and reduce risk of confounding. However, 
due to unfortunate damage of several slides during the transportation between 
Karolinska University Hospital, Sweden and the Pathology Department in Australia, it 
consequently resulted in the loss of multiple pairs, decreasing the power, explaining 
the reasoning behind using unpaired statistical analysis (logistic and linear regression) 
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instead of McNemars’ analysis as initially planned. However, given the random 
damage of slides, it is unlikely to have biased the results apart from reducing power in 
the analysis. The statistical analyses were thus adjusted for age and gender.  
An obvious strength in papers III and IV was the inclusion of around 97% of the 
total Swedish male population in the relevant cage categories at the time as well as the 
very low (1%) loss to follow up. This significantly minimizes the risk of selection 
bias. Missing data on covariates excluded 5549 individuals (12.7%) from the cohort 
and final analysis. The proportion of hospitalization due to symptomatic diverticular 
disease was similar (1.1%) compared with the final group (1.0%).  
6.2.2 Information bias/ Misclassification bias 
Information bias may result from erroneous or inexact sampling of 
information.(165) Misclassification occurs if a participant is wrongly classified in to 
a wrongful category (i.e. light drinker instead of heavy drinker). Non differential vs. 
differential misclassification further differentiates if the misclassification is 
unrelated to other study variables vs. differs according to the value of other study 
variables, such as exposed or unexposed or if they reach the study outcome or not. 
(165)  
In papers I and II, our diagnostic method for identifying diverticulosis was 
colonoscopy, which is considered the gold standard. In addition, experienced 
endoscopists performed the colonoscopies. Further, we used clearly defined variables 
and validated GI symptom and questionnaires such as the ASQ and Rome II modular 
questionnaires, minimizing risk of misclassification of GI symptoms and/or IBS.(159) 
Similarly, in paper I we used the validated HADS questionnaire to assess depression 
and anxiety. While HADS is not the gold standard screening tool for depression and 
anxiety, it is a validated tool to assess prevalence and symptom severity in the general 
population.(162) 
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Any study using questionnaires will have potential for recall bias but it arguably 
depends on the questions asked. In paper I and II, the gastrointestinal symptoms and 
variables were assessed in two questionnaires at different times (the mail 
questionnaires and then at time of the gastroenterology visits), which helps 
minimizing the potential risk for recall bias. Concordance data from a previous study 
on presence or absence of IBS in the ASQ questionnaire (mailed) and the Rome II 
Modular questionnaire (visit), showed a concordance of 86.8%.(166) Medication use 
though was verified with detailed questioning of all medication use during the initial 
gastroenterology visit. However, the time limit of recent antibiotic use was 3 months, 
minimizing the potential for recall bias. Also in Sweden antibiotic prescription is 
tightly regulated and requires a visit with a healthcare provider, further minimizing the 
potential risk for recall bias and thus unlikely to have affected our results.  
To minimize misclassification of mucosal inflammation, biopsies were obtained in 
standard uniform fashion from each colonic segment and not limited to the location of 
diverticula. Further, histology analyses were performed by two independent 
pathologists with good inter-concordance reliability, blinded to both diverticulosis and 
symptomatology status. In addition, CRP was measured and recorded. A possible 
limitation may be the lack of measurement of a correlating mucosal inflammatory 
marker such as fecal calprotectin. Fecal calprotectin was not readily available in 
Sweden at the time of the study though. Moreover histology remains the gold standard 
for evaluating mucosal inflammation. 
 
Papers III and IV included data from the NPR, where primary ICD codes were used 
to identify the outcome of interest (diverticular disease). Although potentially being a 
shortfall, the ICD codes are based on a physicians’ discharge summary and thought to 
be accurate. In an earlier review examining the accuracy of ICD-10 coding for the 
discharge diagnosis of symptomatic diverticular disease (K57.2-9 codes) in 528 
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consecutive admissions at a single center in Sweden, found coding and classification 
to be accurate in 95.8 % of cases with.(16) However, given the inclusion of ICD 8 and 
9 codes in our study the possibility that diverticular hemorrhage may have been 
included within the ICD codes of interest is still possible. Thus, in an effort to further 
minimize the risk of misclassification, all cases with secondary discharge diagnosis of 
gastrointestinal hemorrhage (K92.2, 578.9) were excluded. Another possible 
limitation of using the NPR, is the possibility of missing cases with outcome before 
1987, which is when the NPR attain nationwide coverage. Although this may possibly 
explain why only a few cases were diagnosed with diverticular disease in non-covered 
areas before that time, in 1987 the conscripts would still be younger than age 40, an 
age when diverticulosis and diverticular disease is very rare as reported in paper I.  
 
Other important considerations include the possible misclassifications on exposure 
variables such as parental SES used in paper III. The data was derived from 
Statistics’ Sweden which is a central statistical office established in 1858, with 
reliable data on geographical residency and household income minimizing risk for 
SES misclassification. Similarly, paper IV has the potential of misclassification of 
high BMI due to large muscular mass in muscular athletic men.(167) This risk was 
minimized though by adjusting for cardiovascular fitness.  
6.2.3 Confounding  
Confounding is a frequent issue in epidemiological studies and must always be 
prevented or handled. Per definition, a confounder is linked with both outcome and 
exposure. A confounder though is not an effect of the exposure.(165)  
In studies I and II, inflammatory bowel disease and microscopic colitis were 
excluded a priori to minimize risk of potential confounding on the presence of 
diverticulosis, GI symptoms and presence of mucosal or serological inflammation. 
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While individuals born abroad, in total 11 % of the two parishes’ total inhabitants, 
were excluded a priori, minimizing possible confounding by genetics or difference in 
gut microbiome it does so at the cost of the external validity.  
In study II, we further performed a sensitivity analysis to evaluate confounding by 
smoking, recent antibiotic use and BMI, and the outcomes were essentially 
unchanged. 
One possible limitation in paper III was that the reason for and perception of divorce, 
which might be perceived as either a positive or negative life event, were not asked. 
Similarly, the family environment preceding parental divorce/separation was 
unknown. Hence, stress and possible unknown stress related confounders might be 
possible. Early adverse events have been reported to increase the risk for future 
IBS.(168) IBS like symptomatology in a young population may lead to an increase 
use of colonoscopy despite current Rome based diagnostic criteria, which are entirely 
based on symptom-based diagnostic criteria. This may arguably lead to possible 
detection bias and confounding bias.  
Other possible confounders such as level of hygiene, susceptibility to infections and 
antibiotic use etc., were not measured in this study and may have played a role. 
Longitudinal and in-depth studies on early life stressors including parental divorce, 
over time, should be studied to evaluate causality. 
In paper IV, one potential limitation is the lack of information on dietary factors, 
which is a known risk factor and may affect some of the measured exposure lifestyle 
factors. 
6.3 External validity  
External validity measures the applicability of the results in a particular study 
population to a larger population.  
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Papers I and II includes a representative sample of a Swedish urban population. A 
slight difference in education was noted in our study population compared to the 
Swedish average but more importantly and arguably the greatest limitation is that only 
Swedish born participants were included. Although the reasoning was to limit 
confounding from possible difference in microbiome and lifestyle behaviors, this 
affects the external validity making the results only applicable to native Swedes. 
Otherwise, no main differences were noted among investigated variables between the 
included and excluded participants indicating it to be a good representation of the 
overall Swedish population. 
 
Papers III and IV were population-based studies from the same cohort hence 
improving the external validity to young male populations with similar genetic 
background yet limited in the generalizability to women given the exclusively male 
population. 
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7 DISCUSSION 
In this thesis, diverticulosis and diverticular disease was studied from different 
perspectives. Pathophysiological and epidemiological aspects of the disease were 
addressed.  
7.1 Prevalence and Symptoms 
In spite of the worldwide socioeconomic impact and increasing prevalence of our 
aging and expanding population that diverticular disease poses, true prevalence of 
diverticular disease is uncertain. Current prevalence data has mostly been extracted 
from early autopsy series, hospital admissions, barium radiological studies and more 
recently endoscopic series but of symptomatic subjects.(7) In addition, Swedish 
prevalence data and population-based colonoscopy studies on diverticular disease 
have been lacking.  
This is to my knowledge the first large population-based colonoscopy study 
evaluating the true prevalence of diverticulosis in a community that includes a young 
population. Our findings confirm the current evidence that diverticulosis increases 
with age, but adds that this holds true also in a general community sample.(2, 169-
171) One differentiating strengths in our study is the random population-based study 
design not biased by medical attention and secondary gain seeking individuals. 
Consequently selection bias was minimized and external validity improved. Further, 
the wide age range and high participation rate strengthens the external validity. 
Moreover, colonoscopy performed by experienced endoscopists was our diagnostic 
test of choice. Above differences have been major limitations in prior studies, possible 
explaining the difference in overall prevalence of diverticulosis.(8, 72, 171, 172) 
It is unclear if diverticulosis per se causes gastrointestinal symptoms and namely if 
there is a link between diverticular disease and IBS. (7, 171, 173) Prior studies have 
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had issues with selection bias, leaving the question unanswered. Another problem is 
the differentiation between SUDD and IBS. SUDD, by definition includes abdominal 
pain and/or change in bowel habits due to diverticula in the absence of macroscopic 
colitis or diverticulitis. However, the strong IBS resemblance makes differentiation 
difficult. Although some studies have attempted to differentiate these two conditions 
by clinical characteristics the results have not been validated.(21, 134, 174) While this 
study was not designed to tackle how to differentiate between SUDD and IBS, we 
assessed the prevalence, differences and similarities of gastrointestinal symptoms 
overall among participants with and without diverticulosis.  
Similar to the findings in two population-based non-colonoscopy studies and one 
recent colonoscopy study, we found that diverticulosis is associated with diarrhea-like 
symptoms.(171, 175) In addition, we found that abdominal pain and diarrhea-
predominant IBS was associated with diverticulosis only in participants older than 60 
years of age. This is interesting, as it suggests possible age-specific variations in 
symptomatic diverticulosis. Our study population had comparable IBS prevalence to 
the Swedish community (14.7% vs.6-18%, respectively), suggesting good 
generalizability and confounding by laxative use, microscopic colitis or IBD was 
unlikely given the similar results despite exclusion of possible confounders. 
However, despite the strong association between diverticulosis and diarrhea-
predominant IBS evident by an almost 10 -fold increased OR, given the wide 
confidence intervals caution in interpretation is warranted and confirmation is 
needed.  
The exact pathophysiological mechanisms for diverticulosis-associated diarrhea 
remain unclear but some plausible mechanisms exist. First, age-related alterations in 
the smooth muscle or neuronal functions are possible. However, it is unlikely to 
alone explain the diarrhea.(97) At the time of study one another plausible 
mechanism thought was low-grade inflammation by influence on epithelial cells, 
smooth muscle and enteric nerves function leading to changes in motility and 
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sensation.(121, 123, 125, 176) However, in paper II we found no evidence in this 
study population to support the low-grade inflammation theory. Another hypothesis 
though is possible dysbiosis causing alteration in motility. In our study, 21 out of 
130 participants with diverticular disease reported recent antibiotic use. Participants 
with diverticulosis and reported recent antibiotic use had a significant 4 to 7-fold 
higher likelihood of increased stool frequency, urgency and looser stools. Known 
and accepted mechanisms of antibiotic-associated diarrhea include alteration of the 
gut microbiome as well as direct luminal gastrointestinal irritation of the 
antibiotic.(177) Interestingly though, diarrhea was not observed in participants with 
recent antibiotic use but no diverticulosis, suggesting an alternative explanation. 
While cause-or-effect relationship cannot be established, we hypothesized that 
heightened sensitivity to disturbances in the gut microbiome in patients with 
diverticulosis may be possible.  
Another interesting finding in paper I is the predominant LLQ localization of 
abdominal pain/discomfort found in older participants (above age 60) with 
diverticulosis seen in the sub-analysis derived from the ASQ. While the literature is 
controversial on the definition of SUDD this raises the question whether this indeed is 
SUDD, since a purported difference is the LLQ abdominal pain,(134) and if so 
perhaps the prevalence of SUDD is underestimated. However, the wide confidence 
intervals warrant caution in the interpretation and larger studies to confirm this 
association. 
Lastly, in paper I we found a lack of association between diverticulosis and mood 
disorders. In fact, our participants reported as good self-rated health as those without 
diverticulosis and without an association with anxiety or depression. These findings 
are in contrast to a recent large retrospective chart review of patients with acute 
symptomatic diverticulitis who were found to be 4.7 fold more likely to develop IBS 
after an episode in comparison to controls and 2.2 fold more likely to be diagnosed 
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with mood disorders.(6) Some differences exist. First, while our study is a random, 
wide age range sample of a population, Cohen’s study population was multicultural 
and predominantly a male veteran population, with a mean age of 62.2 years. 
Secondly, while we used the validated HADS questionnaire to evaluate depression 
and anxiety, Cohen et al. used ICD codes from chart review, possibly introducing 
misclassification. HADS while not the gold standard for screening depression and 
anxiety, it is a validated tool to evaluate prevalence and symptom severity in the 
general population.(162)The main and most important difference though is that our 
population did not have a history of acute diverticulitis while patients in Cohen’s 
study did. Hence, it is possible that acute inflammation may be the key trigger for 
developing mood disorder. Nevertheless, prospective studies are warranted to confirm 
this association. 
7.2 Inflammation 
Conflicting literature exists on the role of inflammation in diverticulosis with or 
without symptoms. Kealy et al. described early a microscopically evident increased 
density of lymph node aggregates in necropsied colons of patients with diverticular 
disease when compared to those from patients without diverticular disease, suggesting 
lymphoid follicles may be weak points in the mucosa, and diverticula could develop at 
these points.(178) These findings suggested the possibility of a relationship between 
diverticulosis and inflammation. 
The largest body of evidence for this theory though, is the presence of macroscopic 
colitis in the areas with diverticulosis seen in SCAD. These patients have rectal 
sparing and similarities with IBD, ischemic colitis and infectious colitis histologically, 
with presence of crypt abscesses, crypt distortion and granulomas.(179) (180) 
Diverticular disease without segmental colitis has also been found to have chronic 
inflammation. For example, in resected colon segments for symptomatic 
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uncomplicated diverticular disease without diverticulitis, Horgan and colleagues 
reported the finding of peridiverticular chronic low-grade inflammation and within the 
diverticula in 75 % of 930 resected sigmoid specimens but the inflammation degree 
did not correlate with symptom intensity.(122) Similarly, Tursi and colleagues found 
persistent low-grade inflammation and increased expression of tumor necrosis factor 
alpha in patients with diverticular disease after an episode of diverticular disease. 
(127) However, these studies were not population-based, and included patient 
populations with symptomatic uncomplicated diverticular disease (SUDD), history of 
diverticulitis or significant symptoms requiring surgical resection as symptomatic 
treatment, raising concern for selection bias. Furthermore, pathologists were not 
blinded to the symptom status in all the studies. 
In addition, several studies exist with possible explanatory pathophysiological 
mechanism explaining the link between chronic inflammation in diverticular disease 
and symptoms but results remain unclear. Simpson et al. noted damage to the enteric 
nervous system after recent diverticulitis, correlating with symptom 
persistence.(125) Humes and colleagues found that chronic low-grade inflammation 
could alter the motility and sensation by influencing the function of epithelial cells, 
smooth muscle and enteric nerves.(121) Furthermore, patients with history of acute 
diverticulitis have significant attenuation in serotonin transporter levels, which are a 
primary trigger of gut motility.(126) However, all these studies included subjects 
with history of diverticulitis in contrast to our study population who lacked history 
of diverticulitis. 
In paper II we did not find any association between diverticulosis per se and 
serologic or mucosal inflammation, in any colonic segment, regardless of location of 
diverticula. Moreover, there was no association between symptomatic diverticulosis 
with abdominal pain or diarrhea and serological or mucosal inflammation. The 
population-based study design minimizes selection bias and improves the 
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generalizability. GI symptoms were further well characterized using validated 
modified Rome II questionnaires and the gender and GI symptom distribution was 
similar between included and excluded participants’ support that the study 
population was a good representation of the overall population. Further, the 
diagnostic method for identifying diverticulosis was colonoscopy. While biopsies 
were not targeted to the diverticula per se, the biopsies were obtained in standard 
uniform fashion from each colonic segment and not limited to the location of 
diverticula. Histology analyses were further performed by two independent 
pathologists with good inter-concordance reliability, blinded to both diverticulosis 
and symptomatology status. Lastly, we measured and accounted to for known and 
possible confounders in our analysis. 
Our study complements the recent findings by Peery et al. demonstrating absence of 
colonic mucosal inflammation in diverticulosis or symptomatic diverticulosis.(130) 
While both studies were colonoscopy-based and included study populations with 
absence of past diverticulitis, our study was population-based and assessed the whole 
colon for inflammation, regardless of localization of diverticula, while Peery et al. 
only assessed the sigmoid colon. Furthermore, while Peery et al. measured the 
presence of active immune response by TNF-α messenger RNA, interleukins-6 and 
interleukin-10 levels, we evaluated the actual presence of inflammatory cells, changes 
and gradients.  
Arguably, some limitations need to be mentioned. None of the study participants 
had history of diverticulitis. We can thus not exclude a severe disease subgroup, 
which suffer recurrent episodes of acute diverticulitis where colonic inflammation 
plays a role. Another possible limitation is the lack of a correlating colon mucosal 
inflammatory marker such as fecal calprotectin but it was not readily available in 
Sweden at the time of the study and histology remains the gold standard to evaluate 
mucosal inflammation.  
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The main issue with paper II was missing data. While matching to age (2+/-) and 
gender was done a priori to minimize risk for confounding, missing data by damage 
of slides during transportation between Sweden and Australia occurred, leaving 
discordant pairs and ultimately loss of power. This was the main reason for 
proceeding with logistic and linear regression adjusted for age and gender instead of 
McNemar’s analysis. However, it is unlikely to have affected the results as the 
damage occurred at random with no significant difference when comparing included 
and excluded cases in terms of age, gender, or symptoms. Other possible limitations 
include, underreporting of over the counter NSAID use possibly underestimating the 
presence of mucosal inflammation. However, the detailed questioning of all 
medication use twice and on two different occasions (during the initial 
gastroenterology visit and at time of endoscopy) minimizes the risk for potential 
recall bias and hence unlikely to have altered our results. 
In the symptomatic diverticulosis subanalysis, there was no evidence of association 
between symptomatic diverticulosis with abdominal pain or diarrhea and serological 
or mucosal inflammation throughout the colon. This further extends both Peery et al. 
and Elli et al.’s recent findings of an absence of sigmoidal colonic mucosal 
inflammation, measured by levels of serological immune markers and histological 
cytokine levels in subjects with symptomatic diverticulosis (IBS or abdominal pain) 
and SUDD compared to controls without diverticulosis.(128, 130)  
In conclusion, the findings in paper II suggest that alternate pathophysiological 
mechanisms need to be explored as we found no association between diverticulosis 
and inflammation regardless if symptomatic or not and thus questions the rationale of 
mesalazine use (an anti-inflammatory agent) in symptomatic diverticulosis without 
history of diverticulitis.  
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7.3 Risk Factors 
In spite of emerging data suggesting an increment in incidence of diverticular disease 
in younger individuals and gap of knowledge exists on predictive risk factors in the 
young populations. In adults, epidemiological studies have identified obesity, 
smoking, NSAID use and diet to be risk factors for complicated diverticular disease, 
diverticular bleeding and diverticulitis (12, 13, 16, 90) and low socioeconomic status 
has been linked with increased hospitalization risk for both complicated and 
uncomplicated diverticular disease.(94) The influence of environmental determinants 
during upbringing and late adolescence, such as socioeconomic status, residency 
geography (rural vs. urban) on diverticular disease are unknown and longitudinal 
studies in a young population are lacking.  
Papers III and IV help close this knowledge gap. In this large cohort study of young 
late adolescent males, we found exposure to parental divorce to be associated with a 
49% risk increment for future hospital admission for symptomatic diverticular disease 
compared to conscripts with married parents. While both smoking and risky alcohol 
use was more prevalent in conscripts with divorced parents compared to those with 
married parents, the association between having divorced parents and future risk of 
diverticular disease was not explained by the these lifestyle factors. 
The mechanism by how parental divorce influences future diverticular disease is 
unclear. Considering that parental divorce is among the most commonly endorsed 
adverse and stressful childhood events but also associated with known health 
implications such as adopting risk behaviors in lifestyle, mental health disease and 
substance abuse conditions(181) it is difficult to delineate whether it directly or 
indirectly (as a surrogate marker for stress) influences the risk of future hospital 
admission for symptomatic diverticular disease. Stress per se, may affect gut 
inflammation via the hypothalamic–pituitary–adrenal (HPA) axis and autonomic 
nervous system, stimulating production and activation of proinflammatory cytokines 
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and macrophages and altering intestinal permeability and the gut microbiota.(182) 
One shortcoming in paper III is that family environment preceding parental 
divorce/separation and other early life events were unknown, leaving the role of stress 
and possible stress related confounders unclear. Hence, longitudinal studies assessing 
multiple early life stressors including parental divorce are warranted to establish 
causality. 
The influence of geographical residence on diverticular disease is unclear. In adults, 
an early study found urbanization to be associated with diverticulosis(39) while recent 
large population-based studies found an increased risk for diverticular disease 
(uncomplicated and diverticular disease requiring hospitalization) in residents of small 
cities or rural areas when compared to urban residents.(49, 94) In contrast, early 
exposure of rural residency in the pediatric IBD literature, at diagnosis and at birth, 
has been protective.(183) Similarly, reduced risk for developing IBD have been 
reported with early pet exposure, childhood contact with farm animals and sharing a 
home and beds.(184) However, since diverticular disease is an age dependent disorder 
in difference from IBD, it is plausible that geographical residency plays a role in the 
pathogenesis if exposed late rather than in early life, closer to onset of the disease, 
consequently explaining our results. Other factors such as hygiene, infection 
susceptibility and antibiotic use etc., were not measured in this study, and need to be 
considered as well. 
In paper IV, we found that lifestyle factors high BMI, low cardiovascular fitness, 
smoking and risky alcohol use were all significant and independently associated with 
an increased risk of developing symptomatic diverticular disease requiring 
hospitalization.  
Several epidemiological cohort studies exist with similar findings but this is the first 
study to report data from an exclusively late adolescent cohort.  
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While the causative mechanisms for obesity to increase the risk of symptomatic 
diverticular disease are unknown, some possible mechanisms will be discussed below. 
First, adipose tissue-driven secretion of inflammatory cytokines have been linked with 
immune cell infiltration in muscle and adjacent tissues in obesity (185, 186) and thus 
possibly playing a role in symptomatic of diverticular disease development. Secondly, 
obesity associated gut microbiome disturbance is possible.(187) Although the 
association is complex and poorly understood (188), a predominance of Firmicutes 
over Bacteroidetes has been reported in obese individuals, with opposite pattern in 
lean individuals.(189) Similarly, in SUDD patients similar microbiome patterns 
(predominant Firmicutes strains over Bacteroidetes) have reported when compared to 
controls.(111, 112) Alternatively, the duration of the exposure to being overweight/ 
obesity (a potentially proinflammatory condition) may influence muscular integrity of 
the colon and gut microbiota balance, increasing the risk for developing diverticular 
disease over time. However, this would need confirmation with a longitudinal study. 
Comparable to existing adult data(81), we found that high cardiovascular fitness in 
late adolescence was independently protective against developing symptomatic 
diverticular disease requiring hospitalization. 
In adults, while tobacco use has been associated with increased risk of symptomatic 
and complicated diverticular disease, the dose-response relationship between smoking 
and diverticular disease is unclear. Compared to nonsmokers, Humes and colleagues 
found a dose dependent risk increment in patients smoking >15 cigarettes/ day for 
developing symptomatic diverticular disease. In contrast, while Hjern et al. 24 % 
increase risk of symptomatic diverticular disease in current smokers vs. nonsmokers, a 
dose response effect was not noted.(15, 16) Similar to Hjern et al., we found no dose-
response effect in study IV, and the risk increment in for developing symptomatic 
diverticular disease was similar across smoking categories except for the highest 
category in the multivariate analysis, which is likely explained by the small number of 
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heavy smokers among cases (N=21). Although the precise explanatory mechanisms 
on how smoking influences the pathogenesis and symptomatic diverticular disease are 
unknown, altered colonic structural, decreased blood circulation, imbalance in 
immune cell infiltration, altered colon transit times and gut microbiome, are possible 
Patients admitted for alcoholism were found to have a nearly 3-fold higher risk of 
being hospitalized for diverticulitis when compared to the general population in a 
Danish National Registry study.(86) However, data on alcohol and risk for 
diverticulosis and diverticular disease is conflicting. Two adult prospective 
population-based studies found no independent link between alcohol and diverticular 
disease. (73, 82) In paper IV, late adolescent risky alcohol use but not alcohol per se, 
was found to be independently associated with a 43% increased risk of requiring 
hospital admission for diverticular disease. One possible explanation may be a link 
between risky alcohol use and overall risk behaviors. The lack of association between 
use of recreational drugs and development of diverticular disease however, argues 
against the possible explanation that risk behaviors overall are increased in conscripts 
with risky alcohol use. Alternatively, risky alcohol use may be associated with 
increased risk for comorbidities overall.(190)  
The main limitation in papers III and IV is that the data on variables were only 
collected at baseline and lack of information on dietary factors, Hence, inference on 
whether changes in lifestyle factors and diet impact, and if so and to what extent, on 
developing clinically significant symptomatic diverticular disease requiring 
hospitalization, cannot be made. Thus, studies assessing the impact of lifestyle factor 
modification early and later in life on future symptomatic diverticular disease 
requiring hospital admission are warranted. 
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8 CONCLUSIONS 
Referring to the described aims of the study the following conclusions can be 
formulated: 
1. Diverticulosis is common, and the prevalence is age-dependent 
and similar among women and men. 
2. Diverticulosis is associated with diarrhea and in those older 
than 60 years of age abdominal pain and diarrhea-predominant 
IBS. 
3. In a general community sample, neither asymptomatic nor 
symptomatic diverticulosis, are associated with colonic 
mucosal inflammation. Other explanations for symptomatic 
colonic diverticulosis need to be identified. 
4. Exposure to parental divorce in early life is associated with an 
increased risk of hospital admission for symptomatic 
diverticular disease even after adjustment for lifestyle risk 
factors. 
5. A high BMI, poor cardiovascular fitness, risky alcohol use 
and smoking in late adolescence are associated with an 
increased risk of developing diverticular disease later in life. 
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9 CLINICAL AND SCIENTIFIC IMPLICATIONS 
9.1 Implications for Clinical Practice and Future Studies 
Paper I 
• Identifying the true prevalence of diverticulosis and its association with 
gastrointestinal symptoms in a general population gives us much needed 
insight on the impact and spectrum of the condition. 
• We confirm that diverticulosis is common, increases with age and has no 
gender predilection in the general population. 
• Further, the overall link and age-specific association between diverticulosis 
and diarrhea, abdominal pain and diarrhea-predominant IBS should direct 
future age-specific studies aimed at uncovering the mechanisms underlying 
the development of diverticular disease and possible help identify high risk 
populations. 
 
Paper II 
• No evidence of serological or colonic inflammation in diverticulosis and/or the 
symptoms of diarrhea, abdominal pain or IBS was found. 
• These findings suggest a different pathophysiologic mechanism for 
developing diverticulosis and question the current use of mesalamine in 
SUDD, which purportedly is the result of chronic low grade inflammation. 
• This notion invites longitudinal population-based microbiome studies to 
further study pathophysiological mechanisms. 
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Papers III and IV 
 
• We found that exposure to parental divorce influences the risk for 
development of diverticular disease later in life. 
• This encourages future studies investigating early life events on the 
development for symptomatic diverticular disease 
• It further fuels the current evidence suggesting that adolescence is a risky 
period for developing longstanding behaviors and lifestyle risk factors into 
adulthood. 
• We conclude that being overweight, a smoker, poorly  cardiovascular fit or a 
risky alcohol user in late adolescence are independantly associated with an 
increased risk for develeopingt of clinically signficant diverticular disease 
requiring hospital admission later in life. 
• Having identified these early life risk factors should fuel future studies to 
evaluate to the effect of modifying these factors on the outcome possibly as 
preventable measures. 
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10 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Divertikelsjukdom (tarmfickor) i tjocktarmen är vanligt förekommande och är orsak till 
en stigande samhällsbelastning med höga sjukvårdskostnader. Divertikelsjukdom är 
ovanlig innan 40 års ålder men ökar i förekomst med stigande ålder. Den kliniska 
bilden spänner från ett symtomfritt tillstånd till svårt akut sjukdom som kräver 
sjukhusvård, intravenös antibiotika och vid behov kirurgi. Med en åldrande befolkning 
är kunskap om riskfaktorer för att utveckla divertikelsjukdom viktig. Orsaken till 
divertikelsjukdom är komplext och bristfälligt utforskad. Låggradig inflammation är 
en potentiell underliggande orsak till symtomatisk divertikulos, men 
befolkningsstudier saknas. Kända riskfaktorer att utveckla divertikelsjukdom inkluderar 
genetiska- samt livsstilsfaktorer, men endast vuxenstudier har utförts. 
Syftet med denna avhandling var att kartlägga förekomsten av divertikulos och dess 
samband med mag-tarmsymtom i normalbefolkningen. Vidare var syftet att undersöka 
om låggradig inflammation i tjocktarmen har samband med divertikulos samt 
undersöka om tidiga livsstils- och miljöfaktorer ökar risken att utveckla symptomatisk 
divertikelsjukdom inklusive divertikulit. 
I delarbete I utförde vi en befolkningsbaserad koloskopiundersökning av slump- 
mässigt utvalda vuxna födda i Sverige (18-70 år), där sambandet mellan mag- 
tarmsymtom, psykisk hälsa, koloskopi och divertikulos undersöktes. Studien visade att 
förekomsten av divertikulos är åldersberoende samt att divertikulos är associerat med 
diarré samt buksmärta och irritabel tjocktarm (IBS) hos äldre individer över 60 år. 
Delarbete II är en fallkontrollstudie från samma normalbefolkning som i delarbete I. 
Vi fann att divertikulos med eller utan mag-tarmsymtom är inte förknippat med 
låggradig inflammation vare sig i tjocktarmens slemhinna eller i blodet. 
Delarbetena III och IV var stora befolkningsbaserade kohortstudier, där vi under- sökte 
sambandet mellan livsstils- och miljöexponeringsvariabler och de följande 39 års risk 
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för inneliggande symtomatisk divertikelsjukdom hos unga Svenska män som 
mönstrade år 1969-2009 (n=49 321). I delarbete III, fann vi att unga mönstrade män 
med skilda föräldrar hade ökad risk för framtida behov av sjukhusinlägg för 
behandling av divertikelsjukdom. Vidare fann vi i delarbete IV att övervikt, fetma, 
rökning, riskfyllt alkoholbruk samt dålig fysisk kondition i sen ungdom är förknippat 
med en ökad risk för framtida behov av sjukhusinläggning för behandling av 
divertikelsjukdom. 
Sammanfattningsvis så visar denna avhandling att divertikulos är vanligt före- 
kommande och åldersberoende samt ofta förknippat med diarré, buksmärta och 
irritabel tjocktarm hos normal befolkningen, men inte med låggradig inflammation i 
tjocktarmen. Livsstilsfaktorer som fetma, rökning, riskfyllt alkoholbruk och dålig fysisk 
kondition ökar risken för att utveckla sjukhuskrävande divertikelsjukdom även om 
föräldrar är skilda. 
Framtida studier med fokus på vikten av stressfyllda situationer i barndom och 
framtida sjuklighet i divertikelsjukdom samt behandlingsstudie livsstilsintervention i 
riskgrupper är rekommenderat. 
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